CURRICULUM VITAE December 2019

1. Personal data.

Stephen M. Beverley Address:

Birthdate: 10/25/1951 Department of Molecular Microbiology Male Washington University School of Medicine U.S. citizen 660 S. Euclid Ave. Married, 1 dependent St. Louis, MO 63110 314-747-2630, -2634 FAX [email protected]

2. Education.

Ph.D. - Department of , University of California, Berkeley, June, 1979. Allan C. Wilson, thesis advisor. B.S. - Department of Biology, California Institute of Technology. June 1973 (with honors). Leroy Hood, undergraduate research advisor.

3. Appointments.

2018 – Ernest St. John Simms Distinguished Professor in Molecular Microbiology, Washington University Medical School. 1997-2018 Head, Dept. of Molecular Microbiology, Washington University Medical School. 1997- 2018 Director, Center for Infectious Disease Research, Washington University Medical School 1997-2018 Marvin A. Brennecke Professor in Molecular Microbiology, Washington University Medical School. 1996-2003 Co-founder and Chief Scientist, Symbiontics Inc. 1995-97 Acting Chair, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School. 1993-97 and Daisy Yen Wu Professorship in Biological Chemistry and Molecular Pharmacology, Harvard Medical School. 1992-97 Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School. 1988-92 Associate Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School. 1983-88 Assistant Professor of Pharmacology, Harvard Medical School. 1981-83 Postdoctoral Research Affiliate, Department of Biological Sciences, Stanford University (with R.T. Schimke). 1979-81 Damon Runyon - Walter Winchell Postdoctoral Research Fellow, Department of Biological Sciences, Stanford University (with R.T. Schimke).

4. Honors and Awards. B.S. with honors, California Institute of Technology (1973). Damon Runyon - Walter Winchell Postdoctoral Fellowship (1979-1981). Burroughs Wellcome Scholar in Molecular Parasitology (1985-1990). NIH Merit Award (1992-2002) Hsien Wu and Daisy Yen Wu Professorship in Biological Chemistry and Molecular Pharmacology, Harvard Medical School (1993-7). Roitman Prize (1995). Brennecke Professorship in Molecular Microbiology, Washington University School of Medicine

(1997- ). First Brigitte Ogilvie Lecturer (University of Dundee, 1998). Fellow, Academy of Science of St. Louis (2001- ) American Academy of Microbiology (2004 - ) Rosetta B. Barton Lecturer, University of Oklahoma (2004) Fellow, American Association for the Advancement of Science (2007 - ) Member, National Academy of Sciences of the United States (2013 - ) Fellow, American Society of Tropical Medicine & Hygiene (2016 - ) Peter Raven Lifetime Achievement Award, St. Louis Academy of Sciences (2017) American Society of Microbiology Distinguished Lecturer (2018-2020) Michael Apicelli Distinguished Lecturer (2018), Dept. of Microbiology & Immunology University of Iowa Distinguished Lecturer (2018), Dept. of Microbiology & Immunology, University of Arkansas Medical School Keynote Speaker, Molecular Parasitology Meeting (Woods Hole MA, 2019) Keynote Speaker, Immunoparasitology Meeting (Woods Hole MA 2020)

5. Scientific Societies.

American Society of Tropical Medicine and Hygiene (ASTMH) American Society of Parasitologists (ASP) Society for the Study of Evolution (SSE) American Society of Biochemistry & (ASBMB) American Association for the Advancement of Science (AAAS) American Society of Microbiology (ASM) Society of Protozoologists Glycobiology Society American Society of Cell Biology (ASCB) American Society of Virology (ASV)

6. Professional Service.

Editorial Board, Proceedings of the USA National Academy of Sciences (2016-2020) Member, NIH-HGRI/AID Eukaryotic Pathogens and Vectors Working Group (2006 - present) Associate Editor, PLOS Pathogens (2005 - present) Chair-Elect, Chair and Councilor, American Society of Microbiology Division AA, Free-living, Symbiotic and Parasitic Protists (2003- 6) Editorial Board, Mol. Biochem. Parasitol. (1992 - present) Editorial Board, Eukaryotic Cell (2001 - 2012) Editorial Board, Infection Genetics and Evolution (2001 - 2009) Advisory Board, Mem. Inst. Oswaldo Cruz (Brasil; 1993- 2015) Editorial Board, Kinetoplastid Biology and Disease (2001- present) Sandler Foundation Advisory Board (2001-06) Editorial Board, J. Biological Chemistry (1991- 1995) Board of Reviewers, J. Protozoology/J. Eukaryotic Microbiology (1988-1994)

Member, NIH Study Section on Pathogenic Eukaryotes (2017-2022) National Academy of Sciences USA, Class membership committee (2017 - ) Organizing Board, World 5 Conference (2013) Organizing Board, Kinetoplastid Molecular & Cell Biology Meeting (Woods Hole MA) (2013, 2015, 2019) ASBMB CC & Alice Wang Molecular Parasitology Awards Committee (2011- 15) 2

ATCC Kinetoplastids Focus group (2011 - ) Trypanosomatids Genome Sequencing White Paper Advisory group (2008- ) Structural Genomics of Parasitic Protozoa Advisory Board (Seattle, 2002-6) NIH Study Section Boundaries Panel (2002) Co-organizer, Pasteur Symposium on “The Evolution of Parasites and their Hosts” (, 2000) NIH/NIAID Blue Ribbon Panel on Microbial genomes and genomics (1999) External Review Panel, Institute Pasteur (1999) WHO Committee on Parasite Genomics (1999) NIH Evaluation of the Impact of Genome Science on Mycobacterium Research (1997) Review Board, German Research Council (1996) Advisory Committee, Burroughs Wellcome Fund Molecular Parasitology/Malaria Award (1997-9) Review Panel, Harcourt General Charitable Fund New Investigator Program (1994-6) Member, NIH Study Section on Tropical Medicine (1991-6) Ad Hoc member, NIH Study Sections: Tropical Medicine (9 separate panels) Bacteriology and Mycology (2 panels) Microbiological and Immunological Sciences Special Emphasis Panel (Chair, 1995) WHO Steering Committee on Leishmaniasis (1992-3) WHO Steering Committee on Vaccination against Leishmaniasis (1994-6) Instructor, Woods Hole Course on the Biology of Parasitism (1988-89). Organizer, Woods Hole Molecular Parasitology Meeting (1993-4); Session Chair (1992, 1995, 1997, 1999, 2000, 2002). Coordinator, WHO Leishmania Genome Project (1993-4) Wellcome Foundation Site Visits (1994, 1995, 1998, 2008) Gordon Conference on Parasitism (Chair, 1995; vice-Chair, 1993). ------Co-founder of Symbiontics Inc. (1997; now Zystor Therapeutics, Inc.; sold to Bio-Marin in 2010) and Chief Scientist (1997-2003).

7. Publications.

Published (or in press). 278. Zhang, K. and S.M. Beverley (2019), “Mannogen-ing central carbon metabolism by Leishmania”, Trends in Parasitology (in press). PMCID: in process 277. Bandini, G. S. Damerow, M. L.S. Güther, A. Mehlert, H. Guo, S. M. Beverley and M. A. J. Ferguson (2019) “An essential GDP-Fuc: β-D-Gal α-1,2-fucosyltransferase is located in the mitochondrion of ”, https://www.biorxiv.org/content/10.1101/726117v1. PMCID: in process 276. Filosa, J., C. T. Berry, G. Ruthel, S. M. Beverley, W. C. Warren, C. Tomlinson, P. Myler, E. Dudkin, M. L. Povelones, and M. Povelones (2019), “Dramatic changes in gene expression in different forms of Crithidia fasciculata reveal potential mechanisms for insect-specific adhesion in kinetoplastid parasites”, PLoS Neglected Tropical Diseases 13(7):e0007570. PMCID: 6687205. 275. Inbar, E., J. Shaik, S.A. Iantorno, A. Romano, C. O. Nzelu, K.L. Owens, M. J. Sanders, D.E. Dobson, J. A. Cotton, M. E. Grigg, S. M. Beverley*, and D. L. Sacks*, (* authors contributed equally to this manuscript), “Whole genome sequencing of experimental hybrids

3

reveals meiosis-like sexual recombination in Leishmania” (2019), PLoS Genetics 15(5): e1008042. PMCID: PMC6519804. 274. Ronet, C., K. Passelli, M. Charmoy,, L. Scarpellino, E. Myburgh, Y. Hauyon La Torre, S.J. Turco, J.C. Mottram, N. Fasel, S. Luther, S.M. Beverley, P. Launois, and F. Tacchini- Cottier, “TLR2 signaling in skin non-hematopoietic cells induces early neutrophil recruitment in response to Leishmania major infection” (2019), J. Inv. Dermatology 139: 1318-1328. PMCID: in process. 273. de Carvalho, R.V.H., W. A. Andrade, D. S. Lima-Junior, K. Wang, P. M. Nogueira, J. N. Rugani, R.P. Soares, S.M. Beverley, F. Shao and D. S. Zamboni (2019), “Leishmania Lipophosphoglycan Triggers Caspase-11 and the Non-canonical Activation of the NLRP3 Inflammasome”, Cell Reports 26: 1-9. PMCID: in process. 272. Davenport, B.J., C.G. Martin, S.M. Beverley, D. J. Orlicky, A. Vazquez-Torres, and T.E. Morrison (2018), “SODB1 is Essential for Leishmania Infection of Macrophages and Pathogenesis in Mice”, PLoS Neglected Tropical Diseases 12: e0006921. PMCID: PMC6224164. 271. Kohl, K., H. Zangger, M. Rossi, F. Teixeira, N. Isorce, L-F. Lye, K. L. Owens, S. M. Beverley, A. Mayer and N. Fasel (2018), “Importance of Polyphosphates in the Leishmania life cycle”, Microbial Cell 5:371-384. PMCID: PMC6116282. 270. Robinson, J.I. and S. M. Beverley (2018), “Concentration of 2’C-methyladenosine triphosphate by Leishmania guyanensis enables specific inhibition of the Leishmania RNA virus 1 polymerase”, J. Biol. Chem.293:6460-6469. PMCID: PMC5925801. 269. Brettmann, E.A., L-F. Lye, and S.M. Beverley (2018), “Spontaneous excision and facilitated recovery as a control for phenotypes arising from RNA interference and other dominant transgenes”, Molec. Biochem. Parasitol. 220:42-45. PMCID: PMC5828908. 268. Hartley, M-A., R. O. Eren, F. M. Rossi, Prevel, P. Castiglioni, N. Isorce, C. Desponds, L-F. Lye, S. M. Beverley, S. K. Drexler &, N. Fasel, “Leishmania guyanensis parasites block the activation of the inflammasome by inhibiting maturation of IL-1b (2018), Microbial Cell. 5: 137-149. PMCID: PMC5826701. 267. Grybchuk, D., N. S. Akopyants$, A. Y. Kostygov$, A. Konovalovas, L-F Lye, D. E. Dobson, H. Zangger, N. Fasel, A. Butenko, A. O. Frolov, J. Votýpka, C. M. d'Avila-Levy, P. Kulich, J. Moravcová, P. Plevka, I. B. Rogozin, S. Serva, J. Lukeš, S.M. Beverley*, and V. Yurchenko* (2018), “Viral discovery and diversity in trypanosomatid protozoa with a focus on relatives of the human parasite Leishmania”, Proc. Natl. Acad. Sci. USA 115(3): E506-E515. $,* authors contributed equally to this manuscript. PMCID: PMC5776999. 266. Iantorno. S., C. Durrant, A. Khan, M. J. Sanders, S.M. Beverley, W. Warren, M. Berriman, D. L. Sacks, J. A. Cotton, and M. E. Grigg (2017), “Gene Expression in Leishmania Is Regulated Predominantly by Gene Dosage.”, mBio 12;8(5). pii: e01393-17. PMCID: PMC5596349. 265. Eren, R. O., D. Kopelyanskiy, D. Moreau, J.B. Chapalay, M. Chambon, G. Turcatti, L-F. Lye, S. M. Beverley, and N. Fasel (2018), “Development of a semi-automated image-based high-throughput drug screening system”, Front. Biosci. (Elite Ed.). 10: 242-253. PMCID: PMC5735416. 4

264. Guo, H., N. M. Novozhilova, G. Bandini, S.J. Turco, M. A. J. Ferguson and S. M. Beverley (2017), “Genetic Metabolic Complementation Establishes a Requirement for GDP-Fucose in Leishmania”, J. Biol. Chem. 292: 10696-10708. PMCID: PMC5481574. 263. Rossi, M, P. Castiglioni, M-A. Hartley, R. O. Eren, F. Prével, C. Desponds, D. T. Utzschneider, D. Zehn, M. G. Cusi, F. M. Kuhlmann, S. M. Beverley, C. Ronet, and N. Fasel (2017), “Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis”, Proc. Natl. Acad. Sci. USA 114: 4987- 4992. PMCID: PMC5441690. 262. Matveyev, J.M. P., Alves, M. G. Serrano, V. Lee, A. M. Lara, W. A. Barton, A.G. Costa- Martins, S. M. Beverley, E. P. Camargo, M. M. G. Teixeira, and G. A. Buck (2017), “Evidence for the evolutionary loss of RNAi key determinants in kinetoplastids as a multiple sporadic phenomenon”, J. Mol. Evol. 84: 104-115. PMCID: PMC5744689. 261. Mandell, M.A. and S. M. Beverley (2017), “Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts”, Proc. Natl. Acad. Sci. USA 114: E801-E810. PMCID: PMC5293024. 260. Castiglioni, P., M-A. Hartley, M. Rossi1, F. Prevel, C. Desponds, D. T. Utzschneider, R-O. Eren, H. Zangger, L. Brunner, N. Collin, D. Zehn, F. M. Kuhlmann, S. M. Beverley, N. Fasel and C. Ronet (2017), “Exacerbated Leishmaniasis Caused by a Viral Endosymbiont can be Prevented by Immunization with Its Viral Capsid”, PLoS Neglected Tropical Diseases11(1):e0005240. PMCID: PMC5242429. 259. Kuhlmann, F.M. J.I. Robinson, G. Bluemling, C. Ronet, N. Fasel, and S.M. Beverley (2017), “Anti-viral Screening Identifies Adenosine Analogs Targeting the Endogenous dsRNA Leishmania RNA Virus 1 (LRV1) Pathogenicity Factor”, Proc. Natl. Acad. Sci. USA 114: E811-E819. PMCID: PMC5293060 258. Guimarães, L.H., A. Queiroz, J. A. Silva, S. C. da Silva, V. Magalhães, E. L. Lago, P. R. L. Machado, O. Bacellar, M. E. Wilson, S. M. Beverley, E. M. Carvalho, and A. Schriefer (2016), “Atypical manifestations of cutaneous leishmaniasis in a region endemic for Leishmania (Viannia) braziliensis: clinical, immunological and parasitological aspects”, PLoS Neglected Tropical Diseases 10(12):e0005100. PMCID: PMC5131895. 257. Brettmann, E.A., J. Shaik, H. Zangger, L-F. Lye, F. M. Kuhlmann, N. S. Akopyants, D. M. Oschwald, K.L. Owens, S. M. Hickerson, C. Ronet, N. Fasel, and S. M. Beverley (2016), “Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response”, Proc. Natl. Acad. Sci. USA 113:11998- 12005. PMCID: PMC5131895. 256. Macedo, D.H., A. Menezes-Neto, J. M. Rugani, A. C. Rocha, S. O. Silva, M. N. Melo, L-F Lye, S.M. Beverley, C. M. Gontijo, and R. P. Soares (2016), “Low frequency of LRV1 in Leishmania braziliensis strains isolated from typical and atypical lesions in the State of Minas Gerais, Brazil”, Mol. Biochem. Parasitol.210: 50-54. PMCID: PMC5125831. 255. Hartley, M-A., E. Bourreau, M. Rossi, P. Castiglioni, R. Eren, F. Prevel, P. Couppié, S. Hickerson, P. Launois, S. Beverley, C. Ronet, and N. Fasel (2016), " Leishmaniavirus- Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A " (2016), PLoS Pathogens 12(9):e1005852. PMCID: PMC5033371.

5

254. Eren, R.O., M. Reverté, M. Rossi, M-A. Hartley, P. Castiglioni, F. Prevel, R. Martin, C. Desponds, L-F. Lye, S. K. Drexler, W. Reith, S. M. Beverley, C. Ronet, and N. Fasel (2016), “Mammalian Innate Immune Response to a Leishmania-Resident RNA Virus Increases Macrophage Survival to Promote Parasite Persistence”, Cell Host Microbe 20: 318-28. PMCID: NIHMS867188. 253. Akopyants, N.S., L-F. Lye, D.E. Dobson, J. Lukeš and S.M. Beverley (2016), “A novel bunyavirus-like virus of trypanosomatid protist parasites”, Genome Ann. 4: e00715-16. PMCID: PMC4974306. 252. Lye, L-F., N.S. Akopyants, D.E. Dobson, and S.M. Beverley (2016), “A Narnavirus-like element from the trypanosomatid protist parasite Leptomonas seymouri”, Genome Ann. 4 e00713-16. PMCID: PMC4974305. 251. Akopyants, N.S., L-F. Lye, D.E. Dobson, J. Lukeš and S.M. Beverley (2016), “A Narnavirus in the trypanosomatid protist plant pathogen Phytomonas serpens”, Genome Ann. 4: e00711-16. PMCID: PMC4966457. 250. Mandell, M.A., and S.M. Beverley (2016), “Concomitant immunity induced by persistent Leishmania major does not preclude secondary re-infection: implications for genetic exchange, diversity and vaccination”, PLoS Neglected Tropical Diseases 10(6): e0004811. PMCID: PMC4924822. 249. Beverley, S.M. (2016), “African trypanosomes find a fat haven”, Cell Host Microbe 16: 748-9. PMCID: PMC4986830. 248. Reynolds, D.L., B. T. Hofmeister, L. Cliffe1, T. N. Siegel, B. A. Anderson, S. M. Beverley, R. J. Schmitz, and R. Sabatini (2016), “Base J represses genes at the end of polycistronic gene clusters in Leishmania major by promoting RNAP II termination”, Molecular Microbiology 101: 559-74. PMCID: PMC5038137. 247. Parmentier, L., A. Cusini, N. Müller, H. Zangger , M-A. Hartley, C. Desponds, P. Castiglioni, P. Dubach, C. Ronet, S. M. Beverley, and N. Fasel (2016), “Severe cutaneous leishmaniasis in an HIV patient co-infected with Leishmania braziliensis and its endosymbiotic virus”, American Journal of Tropical Medicine & Hygiene 94: 840-3. PMCID: 4824227. 246. Favila, M.A, N.S. Geraci, N.S., A. Jayakumar, S. M. Hickerson, J. Mostromi, S.J. Turco, S. M. Beverley and M. A. McDowell, “Differential impact of LPG-and PG-deficient Leishmania major mutants on the immune response of human dendritic cells” (2015), PLoS Neglected tropical Diseases: 9(12):e0004238. PMCID: PMC4667916. 245. Valdivia, H.O., J. L. Reis Cunha, G. F. Rodriguez-Luiz. R. P. Baptista. G. C. Baldeviano, R. V. Gerbasi, D. E. Dobson, F. Pratlong, P. Bastien, A.G. Lescano, S. M. Beverley, & D. C. Bartholomeu, “Comparative genomic analysis of Leishmania (Viannia) peruviana and Leishmania (Viannia) braziliensis” (2015), BMC Genomics 16:715. PMCID: PMC4575464. 244. Beverley, S.M. (2015), “CRISPR for Cryptosporidium”, Nature 523: 413-414. PMCID: PMC4620987. 243. Adaui, V., L-F. Lye, N. S. Akopyants, M. Zimic, A. Llanos-Cuentas, L. Garcia, I. Maes, S. De Doncker, D. E. Dobson, J-C. Dujardin, J. Arevalo & S.M. Beverley (2016; e-publication 6

June 2015), “Association of endobiont dsRNA virus LRV1 with treatment failure of human leishmaniasis caused by Leishmania braziliensis in Peru and Bolivia”, J. Infectious Diseases 213: 112-21. PMCID: PMC4676543. 242. Terrazas, C., St. Oghumu, S. Varikuti, D. Martinez-Saucedo, S.M. Beverley and Abhay Satoskar (2015), “Uncovering Leishmania-macrophage interplay using imaging flow cytometry”, J. Immunological Methods 8: 653-7. PMCID: PMC4620550. 241. da Costa-Silva, T.A., S. S. Grecco, F, S. de Sousa, J. H. G. Lago, E. G. A. Martins, C.A. Terrazas, S. Varikuti, S.M. Beverley, A. Satoskar, and A.G. Tempone (2015), “Immunomodulatory and antileishmanial activity of phenylpropanoid dimers isolated from Nectandra leucantha”, J. Natural Products 78: 653-7. PMCID: 4730870. 240. Vasquez, M.A., U. Das, S. M. Beverley, E. Iniguez, L. J. Herrera, J.R. Dimmock, and R. A. Maldonado , “Evaluation of α,β-unsaturated ketones as anti-leishmanial agents” (2015), Antimicrobial Agent and Chemotherapy 59:3598-601. PMCID: PMC4432202. 239. Shaik, J., A. Khan, S. M. Beverley and L.D. Sibley (2015), “ REDHORSE-REcombination and Double crossover detection in Haploid Organisms using next-geneRation SEquencing data” BMC Genomics 16:133. PMCID: PMC4348101. 238. Damasceno, J.D., Beverley, S.M., and L.R. Tosi (2015), “A transposon-based tool for transformation and mutagenesis in trypanosomatid protozoa”, Methods Mol Biol. 2015: 235- 45. PMCID: PMC4287265. 237. Romano, A., E. Inbar, A. Debrabant, M. Charmoy, P. Lawyer, F. Ribeiro-Gomes, M. Barhoumi, M. Grigg, J. Shaik, D. Dobson, S.M. Beverley* and D.L. Sacks* (2014), “Cross- species genetic exchange between visceral and cutaneous strains of Leishmania in the sand fly vector”, Proc. Natl. Acad. Sci. USA 111: 16808-13. PMCID: PMC4250153. * - senior authors contributed equally. 236. Hartley, M-A., S. Drexler, C. Ronet, S. M. Beverley, and Nicolas Fasel (2014), “The Immunologic, Environmental and Phylogenetic Perpetrators of Metastatic Leishmaniasis”, Trends in Parasitology 30:412-422. PMCID: PMC4287268. 235. Campos-Salinas, J., A. Cavazzuti, F. O’Valle, I. Forte-Lago, M. Caro, S. M. Beverley, M. Delgado, and E. Gonzalez-Rey (2014), “Therapeutic efficacy of stable analogues of Vasoactive Intestinal Peptide against pathogens”, J. Biological Chemistry 289:14583-14599. PMCID: PMC4031515. 234. Zangger, H., A. Hailu, C. Desponds, L-F. Lye, N. S. Akopyants, D.E. Dobson, C. Ronet, H. Ghalib, S. M. Beverley and N. Fasel, “Leishmania aethiopica field isolates bearing an endosymbiontic dsRNA virus induce pro-inflammatory cytokine responses” (2014), PLoS Neglected Tropical Disease 8:e2836. PMCID: PMC3998932. 233. Beiting, D. P., L. Peixoto, N. S. Akopyants, S. M. Beverley , E. J. Wherry, D. A. Christian, C. A. Hunter, I. E. Brodsky and D. S. Roos (2014), “Differential induction of TLR3- dependent innate immune signaling by closely related parasite species”, PLoS One 9:e88398. PMCID: PMC3914978. 232. Hsu, F-F, F.M. Kuhlmann, J. Turk and S.M. Beverley (2014), “Multiple-stage linear ion- trap with high resolution mass spectrometry towards complete structural characterization of

7

phosphatidylethanolamines containing cyclopropane fatty acyl chain in Leishmania infantum”, J. Mass Spectrometry 49:201-9. PMCID: PMC4007172. 231. Anderson, B.A., I.L.K. Wong, L. Baugh, G. Ramasamy, P.J. Myler and S. M. Beverley (2013), “Kinetoplastid-specific histone variant functions are conserved in Leishmania major”, Mol. Biochem. Parasitol. 191: 53-7. PMCID: PMC3863619. 230. Campos-Salinas, J., M. Caro, A. Cavazzuti, I. Forte-Lago, S.M. Beverley, F. O’Valle, and E. Gonzalez-Rey, “Antimicrobial Action of Urocortin II: a New Host Defense Peptide” (2013), J. Immunology 191:6040-51. PMCID: PMC3953160. 229. Inbar, E., N. Akopyants, M. Charmoy, A. Romano, P. Lawyer, D-E. A. Elnaiem, F. Kaufmann, R. Patrick, M. Barhoumi, M. Grigg, M. Fay, K. Owens, D.E. Dobson, S.M. Beverley, and D. Sacks (2013), “The mating competence of geographically diverse Leishmania major strains in their natural and unnatural sand fly vectors”, PLoS Genetics 9:e1003672. PMCID: PMC3723561. 228. Liu, D., Z. Mou, I. Okwor, S. M. Beverley, and J. E Uzonna (2013), “Deficiency of Leishmania phosphoglycans influences the magnitude but does not affect the quality of secondary (memory) anti-Leishmania immunity”, PLoS One 8(6):e66058. PMCID: PMC3679009. 227. Mou, Z., H. M. Muleme, D. Liu, P. Jia, I.B. Okwor, S.M. Kuriakose, S.M. Beverley, and J.E. Uzonna (2013), “Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating PD-1-mediated T cell exhaustion”, J. Immunology, 190: 3380-9. PMCID: PMC3737427. 226. Heiss, C., M. L. Skowyra, H. Liu, J. S. Klutts, Z. Wang, M. Williams, D. Srikanta, S. M. Beverley, P. Azadi, and T. L. Doering, “Unusual galactofuranose modification of a capsule polysaccharide in the pathogenic yeast Cryptococcus neoformans” (2013), J. Biol. Chem. 288:10994-1003. PMCID: PMC3630864. 225. Rocha, M. N, C. M. Corrêa, M. N. Melo, S. M. Beverley, O, A. Martins-Fillho. A. Paula Madureira, and R. P. Soares, “An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein” (2012), Diagnostic Microbiology & Infectious Diseases pii: S0732-8893(12)00501-9. PMCID: PMC3733281. 224. Zangger, H., C. Ronet, C. Desponds, F. M. Kuhlmann, J. Robinson, M-A Hartley, F. Prével, P. Castiglioni, F. Pratlong , P. Bastien, N. Müller, L. Parmentier, N. G. Saravia , S.M. Beverley, and N. Fasel (2013), “Detection of Leishmania RNA virus in Leishmania parasites”, PLoS Neglected Tropical Diseases 7:e2006. PMCID: PMC3542153. 223. Feng, X., D. Rodriguez-Contreras, T. Polley, L-F. Lye, D. Scott, R. J. S. Burchmore, S.M. Beverley and S.M. Landfear (2013), “‘Transient’ genetic suppression facilitates generation of hexose transporter null mutants in Leishmania mexicana”, Molecular Microbiology 87(2):412-29. PMCID: PMC3545093. 222. Atayde, V.D., H. Shi, J. Franklin, N.J. Carriero, T. Notton, L-F. Lye, K. Owens, S.M. Beverley, C. Tschudi and E. Ullu (2013), “The structure and repertoire of small interfering RNAs in Leishmania (Viannia) braziliensis reveal diversification in the trypanosomatid RNAi pathway”, Molecular Microbiology 87(3):580-93. PMCID: PMC3556230.

8

221. Lezama-Davila, C., G. Kapadia, A. Marquez-Issac, K.L. Owens, S. Oghumu, S.M. Beverley, and A. Satoskar (2012), “Leishmanicidal activity of two naphthoquinones against Leishmania donovani", Biological and Pharmacological Bulletin 35:1761-4. PMCID: PMCID: PMC3693454. 220. Hartley, M-A., C. Ronet, H. Zangger, S. M. Beverley and N. Fasel (2012), “Leishmania RNA virus: when the host pays the toll”, Frontiers in Cellular Infection & Microbiology 2:99. PMCID: PMC3417650. 219. Laranjeira da Silva,, M.F., R.A. Zampieri, S. M. Muxel, S.M. Beverley and L. M. Floeter- Winter (2012), “Leishmania amazonensis arginase compartmentalization in the glycosome is important for parasite infectivity”, PLoS One 7:e34022. PMCID: PMC3316525. 218. Bruhn, K.W., Birnbaum, R., J. Haskell, V. Vanchinathan, S. Greger, R. Narayan, P. L. Chang, T.A. Tran, S. M. Hickerson, S. M. Beverley, M. E. Wilson, and N. Craft (2012), “Killed but metabolically active Leishmania is a novel whole-cell vaccine for visceral leishmaniasis”, Clinical & Vaccine Immunology 19:490-8. PMCID: PMC3318268. 217. Franco, L.H., S. M. Beverley, & D. S. Zamboni (2012), “Innate immune activation and subversion of mammalian functions by Leishmania Lipophosphoglycan”, J. Parasitol. Research 2012:165126. PMCID: PMC3317186. 216. Ronet, C., S.M. Beverley and N. Fasel (2011), “Un virus, hôte indésirable de L. guyanensis, determine la gravité de la forme mucocutanée de la leishmaniose” (Mucocutaneous leishmaniasis and an undesired passenger), Médecine et Sciences 27: 924-926 (in French) PMCID: PMC371776. 215. Ronet, C., S.M. Beverley and N. Fasel (2011), “Muco-cutaneous leishmaniasis in the New World: the ultimate subversion”, Virulence 2:1-6. PMCID: PMC3260548. 214. Diaz-Gonzalez, R, F. M. Kuhlmann, C, Galan-Rodriguez, L. Madeira da Silva, C.E. Karver, A Rodriguez, S M. Beverley, M. Navarro, and M. P. Pollastri (2011), “The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing”, PLoS Neglected Tropical Diseases 5: e1297. PMCID: PMC3160303. 213. Vickers, T.J. & S.M. Beverley, “Folate metabolic pathways in Leishmania” (2011), Essays in Biochemistry 51: 63–80. PMCID: PMC3278214. 212. Wang, Y., L. Xin, V. Popov, S.M. Beverley, K-P Chang, M. Wang and L. Soong (2011), “The microbicidal effects of human histone proteins H2A and H2B on Leishmania promastigotes but not amastigotes” Infection & Immunity 79:1124-33. PMCID: PMC3067510. 211. Ives, A., C. Ronet, F. Prevel, G. Ruzzante, S. Fuertes-Marraco, F. Schutz, H. Zangger, M. Revaz-Breton, L-F. Lye, S.M. Hickerson, S.M. Beverley, H. Acha-Orbea, P. Launois, N. Fasel and S. Masina (2011), “Leishmania RNA Virus controls the severity of Leishmaniasis” Science 331: 775-778. PMCID: PMC3253482. 210. Dobson, D.E., S. Kamhawi, P. Lawyer, S.J. Turco, S. M. Beverley, and D. L. Sacks (2010), “Leishmania major survival in selective Phlebotomus papatasi sand fly vector requires a specific SCG-encoded lipophosphoglycan galactosylation pattern”, PLoS Pathogens 6: e1001185. PMCID: PMC2978724

9

209. Lye, L-F, S.O. Kang, J. D. Nosanchuk, A. Casadevall, and S. M. Beverley (2011), “Phenylalanine hydroxylase (PAH) from the lower eukaryote Leishmania major”, Molec. Biochem. Parasitol. 175: 58–67. PMCID: PMC2987234. 208. Lye, L-F., K. L. Owens, H. Shi, S.M.F. Murta, A.C. Vieira, S.J. Turco, C. Tschudi, E. Ullu, and S.M. Beverley (2010), “Retention and loss of RNA interference pathways in Trypanosomatid protozoans”, PLoS Pathogens 6: e1001161. PMCID: PMC2965760 207. Feng, X., T. Feistel, C. Buffalo, A. McCormack, E. Kruvand, D. Rodriguez-Contreras, N. S. Akopyants, P.K. Umasankar, L. David, A. Jardim, S. M. Beverley, and S. M. Landfear (2010), “Remodeling of protein and mRNA expression in Leishmania mexicana induced by deletion of glucose transporter genes”, Molec. Biochem. Parasitol. 175: 39-48 PMCID: PMC2974008 206. Thalhofer, C.J., J. W. Graff, L. Love-Homan, S. M. Hickerson, N. Craft, S. M. Beverley and M. E. Wilson (2010), “In vivo imaging of transgenic Leishmania parasites in a live host”, Journal of Visual Experimentation 41: pii: 1980 http://www.jove.com/index/details.stp?id=1980. PMCID: NIHMS264741. 205. Madeira da Silva, L. and S. M. Beverley (2010), “Expansion of the TOR kinase family and function in Leishmania: TOR3 is required for acidocalcisome biogenesis and animal infectivity” Proc. Natl. Acad. Sci. USA 107: 11965-11970. PMCID: PMC2900677 204. Morales, M.A., R. Watanabe, M. Dacher, P. Chafey, J. Osorio y Fortéa, D. A. Scott, S. M. Beverley, G. Ommen, J. Clos, S. Hem, P. Lenormand, J-C. Rousselle, A. Namane, and G. F. Späth (2010), “Phosphoproteome dynamics reveal heat shock protein complexes specific to the Leishmania infectious stage” (2010), Proc. Natl. Acad. Sci. USA 107: 8381-6. PMCID: PMC2889574. 203. Lamerz, A.-C., S. Damerow, B. Kleczka, M. Wiese, G. van Zandbergen, J. Lamerz, A. Wenzel, F-F. Hsu, J. Turk, S.M. Beverley and F.H. Routier (2010), “Deletion of UDP- glucose pyrophosphorylase reveals a UDP-glucose independent UDP-galactose salvage pathway in Leishmania major”, Glycobiology 20: 872-82. PMCID: PMC2900899 202. Waller, J.C., S. Alvarez, V. Naponelli, A. Lara-Nunez, I. K. Blaby, V. Da Silva, M.J. Ziemak, T.J. Vickers, S.M. Beverley, A.S. Edison, J.R. Rocca, J.F. Gregory III, V. de Crécy-Lagard, and A.D. Hanson (2010), “A new role for tetrahydrofolate in the metabolism of iron sulfur clusters in all domains of life”, Proc. Natl. Acad. Sci. USA 107: 10412-7. PMCID: PMC2890791 201. Latorre-Esteves, E., O.E. Akilov, P. Rai, S.M. Beverley and T. Hasan (2010), “Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model for cutaneous leishmaniasis with GFP+ Leishmania major” (2010), J. Biophotonics 3:328- 335. PMCID: PMC2876225 200. Secundino, N., N. Kimblin, N.C. Peters, P. Lawyer, A. A. Capul, S. M. Beverley, S. J. Turco, and D. Sacks (2010), “Proteophosphoglycan confers resistance of Leishmania major to midgut digestive enzymes induced by blood feeding in vector sand flies” Cellular Microbiology 12: 906-918. PMCID: PMC2891569

10

199. Zhang, K. and S. M. Beverley (2010), “Phospholipid and sphingolipid metabolism in Leishmania”, Molecular & Biochemical Parasitology 170 (2010) 55–64. PMCID: PMC2815228 198. Eudes, A., E.R.S. Kunji, A. Noiriel, S.M.J. Klaus, T. J. Vickers, S.M. Beverley, J. F. Gregory III, and A. D. Hanson (2010), “Identification of Transport-Critical Residues in a Folate Transporter from the FBT Family”, J. Biol. Chem. 285:2867-75. PMCID: PMC2807340 197. Svárovská, A., T. H. Ant, V. Seblová, L. Jecná, S. M. Beverley and P. Volf (2010), “Leishmania major Glycosylation Mutants Require Phosphoglycans (lpg2−) but Not Lipophosphoglycan (lpg1−) for Survival in Permissive Sand Fly Vectors”, PLoS Neglected Tropical Diseases 4:e580 PMCID: PMC2797086 196. Zhang, O., M. C. Wilson, W. Xu, F-F. Hsu, J. Turk, F. M. Kuhlmann, Y. Wang, L. Soong, P. Key, S. M. Beverley, and K. Zhang (2009), “Degradation of Host Sphingomyelin is Essential for Leishmania Virulence”, PLoS Pathogens: e1000692. PMCID: PMC2784226 195. Muleme, H.M., R.M. Reguera, A. Berard, I. Okwor, R. Azinwi, S.M. Beverley and J. E. Uzonna, (2009), “Infection with arginase deficient Leishmania major reveals a parasite number-dependent and IL-4-independent regulation of host cellular arginase activity and disease pathogenesis”, J. Immunol. 183: 8068-8076. PMCID: PMC2800308. 194. Okwor, I., D. Liu, S. M. Beverley and J.E Uzonna (2009), “Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via an IL-10-mediated process”, Proc. Natl. Acad. Sci. USA 106: 13951 - 13956. PMCID: PMC2729001. 193. Damasceno, J. D., L.R.O. Tosi, and S. M. Beverley (2010), “A transposon toolkit for gene transfer and mutagenesis in protozoan parasites”, Genetica 138:301–311. PMCID: PMC2807340. 192. Liu, D., C. Kebaier, N. Pakpour, A.A. Capul, S. M. Beverley, P Scott and J. E. Uzonna (2009), “Leishmania major phosphoglycans influence the early host immune response by modulating dendritic cell functions”, Infection & Immunity 77: 3272-3283. PMCID: PMC2715672. 191. Nare, B., L. A. Garraway., T. J. Vickers and S. M. Beverley (2009), “PTR1-dependent synthesis of tetrahydrobiopterin contributes to oxidant susceptibility in Leishmania major”, Current Genetics 55: 287-299. PMCID: PMC2759280. 190. Späth, G. F., P. Schlesinger, R. Schreiber and S.M. Beverley (2009), “A novel role for Stat1 in phagosome acidification and natural host resistance to intracellular infection by Leishmania major”, PLoS Pathogens 5: e1000381. PMCID: PMC2663844 189. Madeira da Silva, L., K.L. Owens, S.F.M. Murta, and S.M. Beverley (2009), “Regulated expression of the Leishmania major surface virulence factor lipophosphoglycan using conditionally destabilized fusion proteins”, Proc. Natl. Acad. Sci. USA 106:.7583-7588. PMCID: PMC2678649. 188. Zhang, K., J. D. Bangs and S.M. Beverley (2010), p. 238-248 in “Sphingolipids in Parasitic Protozoa”, in Sphingolipids as signaling and regulatory molecules, C. Chalfant and M. del

11

Poeta (eds.), Landes Biosciences (Austin TX), 291p. Co-published (with Springer) in Adv Exp Med Biol. (2010), 688:238-48. PMCID: PMC2951629. 187. Gaur, U., M. Showalter, S. Hickerson, R. Dalvi, S. J. Turco, M. E. Wilson, and S. M. Beverley (2009), “Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts”, Exptl. Parasitol. 122: 182-191. PMCID: PMC2720449 186. Akopyants*, N., N. Kimblin*, N. Secondino, R. Patrick, P. Lawyer, D.E. Dobson, S.M. Beverley*, and D.L. Sacks* (2009), “Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector”, Science 324: 265-268. PMCID: PMC2729066 (*1st two authors contributed equally; last two authors contributed equally). (see commentary “Leishmania exploit sex”, Miles, M.A., M. Yeo, and I.L. Mauricio (2009) Science 324: 187-189). 185. Vickers*, T.J., S.M.F. Murta*, M..A. Mandell and S.M. Beverley (2009), “The enzymes of the 10-formyl-tetrahydrofolate synthetic pathway are found exclusively in the cytosol of the trypanosomatid parasite Leishmania major”, Molec. Biochem. Parasitol. 166: 142-152. (1st two authors contributed equally). PMCID: PMC2692634 184. Murta*, S.M.F., T.J. Vickers*, D.A. Scott and S.M. Beverley (2009), “Methylene tetrahydrofolate dehydrogenase/cyclohydrolase and the synthesis of 10-CHO-THF are essential in Leishmania major”, Molecular Microbiology 71: 1386-1401. PMCID: PMC2692627. * (1st two authors contributed equally). 183. Reguera, R.M., R. Balaña-Fouce, M. Showalter, S. Hickerson and S. M. Beverley (2009), “Leishmania major lacking arginase are polyamine auxotrophs but retain infectivity to susceptible BALB/c mice”, Molec. Biochem. Parasitol. 165: 48-56. PMCID: PMC2735255 182. Feng, X., D. Rodriguez-Contreras, C. Buffalo, A. Bouwer, E. Kruvand, S. M. Beverley, and S. M. Landfear (2009), “Amplification of an alternate transporter gene suppresses the avirulent phenotype of glucose transporter null mutants in Leishmania mexicana”, Molecular Microbiology 71: 369-381. PMCID: PMC2729070. 181. Ng, L.G., A. Hsu, M.A. Mandell, C. Hoeller, P. Mrass, A. Iparraguirre, L. L. Cavanagh, S. M. Beverley, P. Scott and W. Weninger (2008), “Migratory dermal dendritic cells act as rapid sensors of protozoan parasites”, PLOS Pathogens 4: e1000222. PMCID: PMC2583051 180. Sutterwala, S., F. F. Hsu, E. S. Sevova, K. J. Schwartz, , K. Zhang, P. Key, J. Turk, S. M. Beverley and J. D. Bangs (2008), “Developmentally Regulated Sphingolipid Synthesis in African Trypanosomes”, Molecular Microbiology 70: 281-96. PMCID: PMC2629665 179. Späth, G.F., M. McDowell, and Stephen M. Beverley (2008), “Leishmania major intracellular survival is not altered in SHP-1 deficient mev or CD45-/- mice”, Exptl. Parasitology 120: 275-279. PMCID:PMC2811416 178. Naponelli, V. A. Noiriel, M. J. Ziemak, S. Beverley, L-F. Lye, A. M. Plume, J. R. Botella, K. Loizeau, S. Ravanel, F. Rébeillé, V. de Crécy, and A. D. Hanson (2008), “Phylogenomic and functional analysis of pterin-4a-carbinolamine dehydratase family (COG2154) proteins in plants and microorganisms”, Plant Physiology 146: 1515-1527. PMCID: PMC2287330

12

177. Scott, D. A., S. M. Hickerson, T. J. Vickers, and S. M. Beverley (2008), “The role of the mitochondrial glycine cleavage complex in the metabolism and virulence of the protozoan parasite Leishmania major”, J. Biol. Chem. 283: 155-165. PMCID: PMC2963101 176. Capul, A.A., S. Hickerson, T. Barron, S. J. Turco, and S. M. Beverley (2007), “Comparisons of mutants lacking the Golgi UDP-Galactose or GDP-Mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania major”, Infection & Immunity 75: 4629-4637. PMCID: PMC1951182 175. Hsu, F-F, Turk, J., Zhang, K. and S. M. Beverley (2007), “Characterization of Inositol Phosphorylceramides from Leishmania major by tandem mass spectrometry with electrospray ionization”, J. Am. Soc. Mass Spectrometry 18: 1591-1604. PMCID: PMC2065762 174. Buck, G., M. Berriman, J. Donelson, N. El-Sayed, J. Kissinger, L. Simpson, A. Tait, M. Teixera, and S. M. Beverley (2007), “Pathogenomics of Trypanosomatid parasites”, NIHGRI White Paper, http://www.genome.gov/Pages/Research/DER/PathogensandVectors/PathogensofTrypanoso matid.pdf. 173. Capul, A.A., T. Barron, D. E. Dobson, S. J. Turco, and S. M. Beverley (2007), “Two functionally divergent UDP-Gal nucleotide-sugar transporters participate in phosphoglycan synthesis in Leishmania major”, J. Biological Chemistry 282: 14006-14017. PMCID: PMC2807729 172. Zhang, K., J. M. Pompey, F-F Hsu, P. Key, P. Bandhuvula, J.D. Saba, J. Turk, and S.M. Beverley (2007), “Redirection of sphingolipid metabolism towards ethanolamine synthesis in Leishmania”, EMBO J. 26:1094-1104. 171. Myskova, J., M. Svobodova, M., S.M. Beverley, and P. Volf (2007), “An LPG-independent adherence paradigm for Leishmania – sand fly interactions in permissive vectors”, Microbes & Infection 9:317-324. 170. Vickers, T.J., G. Orsomando, R. D. de la Garza, D. A. Scott, S. O. Kang, A.D. Hanson and S. M. Beverley (2006), “Biochemical and genetic analysis of methylenetetrahydrofolate reductase in Leishmania metabolism and virulence”, J. Biological Chemistry 281: 38150– 38158. 169. Dobson, D.E., L. D. Scholtes, P. J. Myler, S.J. Turco, and S. M. Beverley (2006), “Genomic organization and expression of the expanded SCG/L/R gene family of Leishmania major: internal clusters and telomeric localization of SCGs mediating species-specific LPG modifications”, Mol Biochem Parasitol. 146: 231-241. 168. Goswami, M., D. E. Dobson, S. M. Beverley & S. J. Turco (2006), “Demonstration by Heterologous Expression that the Leishmania SCA1 Gene encodes an Arabinopyranosyltransferase” Glycobiology 16:230-236. 167. Kébaïer, C., J.E. Uzonna, S.M. Beverley, and P. Scott (2005), “The presence of persistent attenuated Leishmania major parasites is not sufficient to provide protective immunity in C57BL/6 mice”, Infection & Immunity 74: 77-80. 166. Schüttelkopf, A.W., L. W. Hardy S. M. Beverley and W.N. Hunter (2005), “Structures of Leishmania major pteridine reductase complexes reveal the active site features important 13

for ligand binding and to guide structure-based inhibitor design”, J. Mol. Biol. 352: 105- 116. 165. Ivens, A.C., (50+ authors, including S.M. Beverley), & P. J. Myler, “Genome sequence of the kinetoplastid parasite Leishmania major” (2005), Science 309:436-442. 164. Casagrande, L., J.C. Ruiz, S.M. Beverley, & A. K. Cruz (2005), “Identification of DNA fragments which increase mitotic stability of linear episomal DNAs in Leishmania major“, International Journal for Parasitology 35: 973-980. 163. Beverley, S. M., K. L. Owens, M. Showalter, C. L. Griffith, T. L. Doering, V. C. Jones, and M. R. McNeil (2005), “Eukaryotic UDP-galactopyranose mutase (GLF gene) in microbial and metazoal pathogens”, Eukaryot Cell 4:1147-1154. 162. Segawa, H., R. Soares, M. Kawakita, S.M. Beverley and S. J. Turco (2005), “Reconstitution of GDP-Man Transport Activity with Purified Leishmania LPG2 Protein in Proteoliposomes”, J. Biol. Chem. 280: 2028 -2035. 161. Zhang, K., F-F. Hsu, D. A. Scott, R. Docampo, J. Turk, and S. M. Beverley (2005), “Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis”, Mol.Microbiol. 55:1566-1578. 160. Beverley, S.M. & D.E. Dobson (2004), “Flypaper for parasites”, Cell 119:311-312. 159. Boulanger, N., C. Lowenberger, P. Volf, R. Ursic, L. Sigutova, L. Sabatier, M. Svobodova, S.M. Beverley, G. Späth, R. Brun, B. Pesson, and P. Bulet (2004), “Characterization of a defensin from the sand fly Phlebotomus duboscqi induced by challenge with bacteria or the protozoan parasite Leishmania major”, Infection & Immunity 72: 7140-6. 158. Zaph, C., J. Uzonna, S.M. Beverley, and P. Scott (2004), “Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites”, Nature Medicine 10:1104-1109. (see commentary: Seder and Sacks “Memory may not need reminding”, Nature Medicine 10: 1045-1047). 157. Späth, G. L-F. Lye, H. Segawa, S. J. Turco, and S. M. Beverley (2004), “Identification of a compensatory mutant (lpg2-REV) in Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates, and its significance to virulence and immunization strategies”, Infection & Immunity 72:3622-3627. 156. Akopyants, N.S., R. S. Matlib, B. H. Brownstein, G. D. Stormo, and S. M. Beverley (2004), “Expression profiling using a random genomic DNA microarray identifies differentially expressed genes associated with three major developmental stages of the protozoan parasite Leishmania major”, Molec. Biochem. Parasitol. 136:71-86. 155. Zhang, K., T. Barron, S.J. Turco, and S.M. Beverley (2004), “The LPG1 family of Leishmania major”, Molec. Biochem. Parasitol. 136:11-23. 154. Uzonna, J., G. Späth, S. M. Beverley, and P. Scott (2004), “Vaccination with phosphoglycan-deficient lpg2- knockout Leishmania major protects highly susceptible mice from virulent challenge”, J. Immunology 172: 3793-7.

14

153. Duncan, R., P. Salotra, N. Goyal, N. Akopyants, S.M. Beverley, and H. Nakhasi (2004), “The application of gene expression microarray technology to Kinetoplastid research”, Current Molecular Medicine 4: 611-621. 152. Zhang, K., M. Showalter, J. Revollo, F-F. Hsu, J. Turk, and S.M. Beverley (2003), Sphingolipids are essential for differentiation but not growth in Leishmania”, EMBO J. 22: 6016-26. 151. Zufferey, R., S. Allen, T. Barron, D.R. Sullivan P.W. Denny, I.C. Almeida, D.F. Smith, S. J. Turco, M.A.J. Ferguson, and S.M. Beverley (2003). “Ether phospholipids and glycosylinositolphospholipids (GIPLs) are not required for amastigote virulence nor for inhibition of macrophage activation by Leishmania major”, J. Biol. Chem. 278: 44708-18. 150. Späth, G., L-F. Lye, H. Segawa, D. L. Sacks, S. J. Turco, and S. M. Beverley (2003), “Persistence without pathology in phosphoglycan-deficient Leishmania major”, Science 301: 1241-3. 149. Späth, G., L. A. Garraway, S. J. Turco, and S. M. Beverley (2003), “The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts”, Proc. Natl. Acad. Sci. U.S.A. 100: 9536-41. 148. Marchini, J.F.M., A.K. Cruz, S.M. Beverley, and L.R.O. Tosi (2003), “The H region HTBF gene mediates terbinafine resistance in Leishmania major”, Molec. Biochem. Parasitol. 131: 77-81. 147. Goyard, S. H. Segawa, J. Gordon, M. Showalter, R. Duncan, S. J. Turco, and S. M. Beverley (2003), “An in vitro system for differentiation and genetic studies of Leishmania donovani phosphoglycans”, Molec. Biochem. Parasitol. 130: 31-42. 146. Dobson, D.E., B. J. Mengeling, S. Cilmi, S. Hickerson, S. J. Turco and S. M. Beverley (2003), “Identification genes encoding the arabinosyl transferases (SCA) mediating developmental modifications of lipophosphoglycan (LPG) required for sand fly transmission of Leishmania major”, J. Biol. Chem. 278: 28840-28848. 145. Coelho, A.C., S.M. Beverley, and P.C. Cotrim (2003), “Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania”, Molec. Biochem. Parasitol. 130: 83-90. 144. Robinson, K.A., S. Goyard, and S. M. Beverley (2004), “in vitro shuttle mutagenesis using engineered Mariner transposons”, in Methods in Molecular Biology: Parasite Genomics Protocols, Sarah Melville, Editor; Humana Press, 270: 299-318. 143. Robinson, K.A. and S. M. Beverley (2003), “Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania”, Molec. Biochem. Parasitol. 128: 217-228. 142. Atreya, C.E., E. F. Johnson, J.J. Irwin, A. Dow, K. M. Massimine, I. Coppens, V. Stempliuk, S.M. Beverley, K.A. Joiner, B. K.Shoichet, and K. S. Anderson (2003), “A Molecular Docking Strategy Identifies Eosin B as a Non-Active Site Inhibitor of Protozoal Bifunctional Thymidylate Synthase-Dihydrofolate Reductase”, J. Biological Chemistry 278: 14092-14100.

15

141. Dobson, D.E., L. Scholtes, K. Valdez, D. R. Sullivan, B. J. Mengeling, S. Cilmi, S. J. Turco, and S. M. Beverley (2003), “Functional Identification of Galactosyltransferases (SCGs) required for species-specific modifications of the lipophosphoglycan (LPG) adhesin controlling Leishmania major-sand fly interactions”, J. Biological Chemistry 278: 15523-15531. 140. Beverley, S.M. (2003), “Protozomics: trypanosomatid parasite genetics comes of age”, Nat Rev Genet 4:11-19. 139. Gao, L-Y., R. Groger, J. Cox, S.M. Beverley, E. Lawson, and E. J. Brown (2003), “Transposon mutagenesis of Mycobacterium marinum reveals a link between pigmentation and intracellular survival”, Infection & Immunity 71: 922-29. 138. Amaral, V.F., A. Teva, M.P. Oliveira-Neto, A.J. Silva, M.S. Pereira, E. Cupolillo, R. Porrozzi, S.G. Cotinho, C. Pirmez, S.M. Beverley and G. Grimaldi Jr. (2002), “Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania major vaccines in a Rhesus monkey (Macaca mulatta) model of the human disease”, Memorias do Instituto Oswaldo Cruz 97: 1041-1048. 137. Lye, L-F., M. Cunningham, and S.M. Beverley (2002), “Characterization of quinonoid- Dihydropteridine Reductase (QDPR) from the lower eukaryote Leishmania major”, J. Biol. Chem. 277: 38245-38253. 136. Descoteaux, A., H. A. Avila, K. Zhang, S. J. Turco, and S.M. Beverley (2002), “Leishmania LPG3 encodes a GRP94 homolog required for phosphoglycan synthesis implicated in parasite virulence but not viability”, EMBO J. 21: 1-12. 135. Breitling, R., S. Klingner, R. Pietrucha, A. Geyer, G. Ehrlich, N. Callewaert, A. Müller, K- H Gührs, R. Contreras, S.M. Beverley, and K. Alexandrov (2002), “Kinetoplastida as a novel platform for protein research and production”, Protein Expression & Purification 25: 209-18. 134. Myler, P.J., S.M. Beverley, A.K. Cruz, D.E. Dobson, A.C. Ivens, P.D. McDonagh, R. Madhubala, S. Martinez-Calvillo, J.C. Ruiz, A. Saxena, E. Sisk, S.M. Sunkin, E. Worthey, S. Yan, and K.D. Stuart (2001), “The Leishmania genome project: new insights into gene organization and function”, Med. Microbiol. Immunol. 190: 9-12. 133. Goyard, S., L.R.O. Tosi, J. Gouzova, J. Majors, and S.M. Beverley (2001), “New Mos1 mariner derivatives and transposition assays suitable for the recovery of gene fusions in vivo and in vitro”, Gene 280: 97-105. 132. Späth, G.F. and S. M. Beverley (2001), “A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation”, Exptl. Parasitol. 99: 97-103. 131. Beverley, S.M. (2003), “Genetic and genomic approaches to the analysis of Leishmania virulence”, in Molecular & Medical Parasitology, J. Marr, T. Nilsen and R. Komuniecki, editors, Academic Press, New York, pages 111-122. 130. Beverley, S.M., N.S. Akopyants, S. Goyard, R.S. Matlib, J.L. Gordon, B.H. Brownstein, G.D. Stormo, E.N. Bukanova, C.T. Hott, F. Li, S. MacMillan, J.N. Muo, L.A. Schwertman, M.R. Smeds and Y. Wang (2002), “Putting the Leishmania genome to work: functional

16

genomics by transposon trapping and expression profiling”, Philosophical Transactions B of the Royal Society: Biological Sciences 357: 47-53. 129. Selva, E.M., K. Hong, G-H. Baeg, S.M. Beverley, S.J. Turco, N. Perrimon and U. Häcker (2001),“Dual role of the fringe connection gene in both wingless and fringe-dependent signaling events”. Nature Cell Biol. 3: 809-815. 128. Gourley, D.G., A.W. Schüttelkopf, G.A. Leonard, J. Luba, L.W. Hardy, S.M. Beverley and W.N. Hunter (2001), “Structure and mechanism of Leishmania pteridine reductase correlate pterin metabolism with antifolate drug resistance” Nature Structural Biol. 8: 521- 525. 127. Sunkin, S.M., P. McDonagh, M.L. Cunningham, S.M. Beverley, K. Stuart and P.J. Myler (2001), “Conservation of the LD1 region in Leishmania includes DNA implicated in LD1 amplification”, Molec. Biochem. Parasitol. 113: 315-321. 126. Cunningham, M.L, R. Titus, S.J. Turco and S.M. Beverley (2001), “Regulation of differentiation to the infective stage of the protozoan parasite Leishmania by tetrahydrobiopterin”, Science 292: 285-7. 125. Turco, S.J., G.F. Späth and S.M. Beverley (2001), “Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species”, Trends in Parasitology 17: 223-226. 124. Cunningham, M.L. and S.M. Beverley (2001), “Pteridine salvage throughout the Leishmania infectious cycle and the implications for antifolate chemotherapy”, Molec. Biochem. Parasitol. 113: 199-213. 123. Akopyants, N.S., S.W. Clifton, J. Martin, D. Pape, T. Wylie, L. Li, J.C. Kissinger, D.S. Roos, and S.M. Beverley (2001), “A Survey of the Leishmania major Friedlin strain VI genome by Shotgun Sequencing: A Resource for DNA Microarrays and expression profiling”, Molec. Biochem. Parasitol. 113: 337-340. 122. Streit, J.A., T.J. Recker, F. Gueiros-Filho, S.M. Beverley, and M.E. Wilson (2001), “Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infectious with virulent but not avirulent organisms”, J. Immunol. 166: 1921-9. 121. Gehring, A.M., J.R. Nodwell, S.M. Beverley, and R.M. Losick (2000), “Genome-wide insertional mutagenesis in Streptomyces coelicolor identifies additional genes involved in morphological differentiation”, Proc. Natl. Acad. Sci. USA 97: 9642-7. 120. Coates, C.J., N. Jasinskiene, D. Morgan, L.R.O. Tosi, S.M. Beverley, and A.A. James (2000) “Purified mariner (Mos1) transposase catalyzes the integration of marked elements into the germ-line of the yellow fever mosquito, Aedes aegypti”. Insect Biochemistry and Molecular Biology 30: 1003-1008. 119. Späth, G.F., L. Epstein, B. Leader, S.M. Singer, H.A. Avila, S.J. Turco and S.M. Beverley (2000), “Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major”, Proc. Natl. Acad. Sci. USA 97: 9258-9263. 118. Mamoun, C.B., I.Y. Gluzman, S.M. Beverley and D.E. Goldberg (2000), “Transposition of the Drosophila element mariner within the human malaria parasite Plasmodium falciparum”. Molec. Biochem. Parasitol. 110: 405-408.

17

117. Carrillo, M.B., W. Gao, W. M. Herrera, J. Moore, J. Alroy, S.M. Beverley, and M.A. Pereira (2000), “Heterologous expression of Trypanosoma cruzi trans-sialidase in Leishmania enhances virulence”, Infection & Immunity 68: 2728-34. 116. Goyard, S. and S.M. Beverley (2000), “Blasticidin S resistance: a new independent dominant selectable marker for stable transfection of Leishmania”, Molec. Biochem. Parasitol. 108: 249-252. 115. Tosi, L.R.O, and S. M. Beverley (2000), “cis and trans factors affecting Mos1 mariner evolution and transposition in vitro, and its application to functional genomics”, Nucleic Acids Res. 28: 784-790. 114. Hong, K., D. Ma, S.M. Beverley, and S.J. Turco (2000), “The Leishmania GDP-Mannose transporter is an autonomous, multi-specific, hexameric complex of LPG2 subunits”, Biochemistry 39: 2013-2022. 113. Sacks, D.L., G. Modi, E. Rowton, G. Späth, L. Epstein, S.J. Turco and S.M. Beverley (2000), “The role of phosphoglycans in Leishmania - sand fly interactions”, Proc. Natl. Acad. Sci. U. S. A. 97: 406-11. 112. Chakkalath, H.R., A.A. Siddiqui, A.H. Shankar, D.E. Dobson, S.M. Beverley, and R.G. Titus (2000), Priming of a b-galactosidase (bGAL)-specific type 1 response in BALB/c mice infected with bGAL-transfected Leishmania major", Infection & Immunity 68: 809- 814. 111. Brodskyn, C., S.M. Beverley, and R.G. Titus (2000), “Virulent or avirulent (dhfr-ts-) Leishmania major elicit predominantly a type-1 cytokine response by human cells in vitro”, Clinical and Experimental Immunology 119: 299-304. 110. Cotrim, P.C., L.K. Garrity, and S.M. Beverley (1999), “Isolation of genes mediating resistance to inhibitors of nucleoside and ergosterol metabolism in Leishmania by over- expression/selection”, J. Biol. Chem. 274: 37723-37730. 109. Clayton, C, S. Ha, L. Rusché, C. Hartmann, and S.M. Beverley (2000), “Tests of heterologous promoters and intergenic regions in Leishmania major” Molec. Biochem. Parasitol. 105: 163-167. 108. Lemley, C.B., S. Yan, V.S. Dole, R. Madhubala, M.L. Cunningham, S.M. Beverley, P.J. Myler, and K.D. Stuart (1999), “The Leishmania donovani LD1 locus gene ORFG encodes a biopterin transporter (BT1)” Molec. Biochem. Parasitol. 104: 93-105. 107. Cormack, B., B.T. Rouse, and S.M. Beverley (1999), “Host-microbe interactions: fungi/viruses/parasites. Editorial Overview: The emergence of protozoan microbiology”, Current Opinions in Microbiology 2: 343-347. 106. Gourley, D., J. Luba, L.W. Hardy, S.M. Beverley, and W.N. Hunter (1999), “Crystallization of recombinant Leishmania major Pteridine Reductase 1 (PTR1)”, Acta Crystallographica D Biol Crystallogr. 55: 1608-10. 105. Mamoun, C., I.Y. Gluzman, S. Goyard, S.M. Beverley, and D.E. Goldberg (1999), “A set of independent selectable markers for transfection of the human malaria parasite Plasmodium falciparum”, Proc. Natl. Acad. Sci. USA 96: 8716-8720.

18

104. Veras, P.S.T., C.I. Brodskyn, F. Balestieri, L.A.R. de Freitas, A.P.S. Ramos, A.R.P. Queiroz, A. Barral, S.M. Beverley and M. Barral-Netto (1999), “A dhfr-ts- Leishmania major knockout mutant cross-protects against Leishmania amazonensis”, Memorias do Oswaldo Cruz 94: 491-496. 103. Wang, Y., K. Dimitrov, L.K. Garrity, S. Sazer, and S.M. Beverley (1998), “Stage-specific activity of the Leishmania major CRK3 kinase and functional rescue of a Schizosaccharomyces pombe cdc2 mutant”, Mol. Biochem. Parasitol. 96: 139-150. 102. Vasudevan, G., N.S. Carter, M.E. Drew, S.M. Beverley, M.A. Sanchez, A. Seyfang, B. Ullman and S. Landfear (1998), “Cloning of Leishmania nucleoside transporter genes by rescue of a transport-deficient mutant”, Proc. Natl. Acad. Sci. USA 95: 9873-9878. 101. Clayton, C., M. Adams, R. Almeida, T. Baltz, M. Barrett, P. Bastien, S. Belli, S.M. Beverley, N. Biteau, J. Blackwell, C. Blaineau, M. Boshart, F. Bringaud, C. Clayton, A. Cruz, W. Degrave, J. Donelson, N. El-Sayed, G. Fu, K. Ersfeld, W. Gibson, K. Gull, A. Ivens, J. Kelly, D. Lawson, J. Lebowitz, P. Majiwa, K. Matthews, S. Melville, G. Merlin, P. Michels, P. Myler, A. Norrish, F. Opperdoes, B. Papadopoulou, M. Parsons, T. Seebeck, D. Smith, K. Stuart, M. Turner, E. Ullu, and L. Vanhamme (1998), “Genetic nomenclature for Trypanosoma and Leishmania”, Mol. Biochem. Parasitol. 97: 221-224. 100. Descoteaux, A., B.J. Mengeling, S.M. Beverley, and S.J. Turco (1998), “Leishmania donovani has distinct mannosylphosphoryltransferases for the initiation and elongation phases of lipophosphoglycan repeating unit biosynthesis”. Mol. Biochem. Parasitol. 94: 27- 40. 99. Luba, J.L., B. Nare, P-H. Liang, K.S. Anderson, S.M. Beverley, and L.W. Hardy (1998), “Leishmania major pteridine reductase 1 (PTR1) belongs to the short chain dehydrogenase family: stereochemical and kinetic evidence”, Biochemistry 37: 4093-4104. 98. Beverley, S.M., and S.J. Turco (1998), “Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania”, Trends Microbiol. 6: 35-40. 97. Hardy, L.W., W. Matthews, B. Nare, and S.M. Beverley (1997), “Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways” Experimental Parasitology 87: 157- 169. 96. Mengeling, B.J., S.M. Beverley, and S.J. Turco (1997), “Designing glycoconjugate biosynthesis for an insidious intent: phosphoglycan assembly in Leishmania parasites”. Glycobiology 7: 873-880. 95. Gueiros-Filho, F.J., and S.M. Beverley (1997), “Trans-kingdom transposition: mobilization of the Drosophila element mariner in the protozoan Leishmania”, Science 276: 1716-1719. 94. Garraway, L.A., L.R.O. Tosi, Y. Wang, J.B. Moore, D.E. Dobson, and S.M. Beverley (1997), “Insertional mutagenesis using a modified in vitro Ty1 transposition system”, Gene 198: 27-35. 93. Nare, B., L. Hardy, and S.M. Beverley (1997), “ New approaches to Leishmania chemotherapy: Pteridine Reductase 1 (PTR1) as a target and modulator of antifolate sensitivity”, in Molecular Basis of Drug Design and Resistance, Coombs, G.H. and Croft, S.L. (eds), Parasitology 114: S102-S110, Cambridge University Press.

19

92. Nare, B., L. Hardy, and S.M. Beverley (1997), "The roles of Pteridine Reductase 1 (PTR1) and Dihydrofolate Reductase-Thymidylate Synthase (DHFR-TS) in pteridine metabolism in Leishmania", J. Biol. Chem. 272: 13883-13891. 91. Garcia, M.R., S. Graham, R.A. Harris, S.M. Beverley, and P.M. Kaye (1997), “Epitope cleavage by Leishmania endopeptidase(s) limits the efficiency of the ‘exogenous’ pathway of MHC class I associated antigen presentation”. Eur. J. Immunol. 27: 1005-1013. 90. Tosi, L.R.O., L. Casagrande, S.M. Beverley, and A.K. Cruz (1997), “Physical mapping across the dihydrofolate reductase-thymidylate synthase chromosome of Leishmania major”. Parasitology 114: 521-530. 89. Racoosin, E.L., and S.M. Beverley (1997), “Leishmania major: Promastigotes induce expression of a subset of chemokine genes in murine macrophages”. Experimental Parasitology 85: 283-295. 88. Beverley, S.M. (1996), “Hijacking the cell: parasites in the driver’s seat”. Cell 87: 787-789. 87. Ma, D., D. Russell, S.M. Beverley, and S.J. Turco (1997), "Golgi GDP-mannose uptake requires Leishmania LPG2: a member of a eukaryotic family of potential nucleotide-sugar transporters". J. Biol. Chem. 272: 3799-3805. 86. Flaspohler, J.A., W.L. Rickoll, S.M. Beverley, and M. Parsons (1997), “Functional identification of a Leishmania gene related to the peroxin 2 gene reveals common ancestry of glycosomes and peroxisomes”. Mol. Cell. Biol.17: 1093-1101. 85. Beverley, S.M. (1995), “Identification of Leishmania genes by functional complementation: application to drug resistance and virulence”. Memorias do Instituto Oswaldo Cruz 90(I): 12-14. 84. Turco, S.J., and S.M. Beverley (1996) “A genetic analysis of the biosynthetic pathway of the Leishmania virulence factor LPG”, Trypanosomiasis and Leishmaniasis (G. Hide, J.C. Mottram, G.H. Coombs, P.H. Holmes, eds), CAB International, Glasgow, p. 79-88. 83. Ha, D.S., J.K. Schwarz, S.J. Turco, and S.M. Beverley (1996), "Use of the green fluorescent protein as a marker in transfected Leishmania ". Mol. Biochem. Parasitol. 77: 57-64. 82. Beverley, S.M., and S.J. Turco (1995), "Identification of genes mediating lipophosphoglycan (LPG) biosynthesis by functional complementation of Leishmania donovani mutants", Annals Trop. Medicine & Parasitology 89: s11-18. 81. Ma, D., S.M. Beverley, and S.J. Turco (1996), “Leishmania donovani possess a NADPH- dependent glyceryl ether monooxygenase”. Biochem. Biophys. Res. Commun. 227: 885- 889. 80. Gueiros-Filho, F.J., and S.M. Beverley (1996), "Selection against Dihydrofolate Reductase- Thymidylate Synthase (DHFR-TS) as a probe of genetic alterations in Leishmania". Mol. Cell. Biol. 16: 5655-5663. 79. Descoteaux, A., L. Ya, S.J. Turco, and S.M. Beverley (1995), "A specialized pathway affecting virulence glycoconjugates in Leishmania". Science 269: 1869-1872.

20

78. Cupolillo, E., G. Grimaldi Jr., H. Momen, and S.M. Beverley (1995), "Intergenic Region Typing (IRT): a rapid molecular approach to the characterization and evolution of Leishmania", Molec. Biochem. Parasitol. 73: 145-155. 77. Titus, R.G., F.J. Gueiros-Filho, L.A.R de Freitas, and S.M. Beverley (1995), "Development of safe live Leishmania vaccine lines by gene replacement", Proc. Natl. Acad. Sci. USA 92: 10267-10271. 76. Callahan, H.L., W.L. Roberts, P.M. Rainey, and S.M. Beverley (1994), "The PGPA gene of Leishmania major mediates antimony (SbIII) resistance by decreasing influx and not by increasing efflux", Mol. Biochem. Parasitol. 68:145-150. 75. Bello, A.R., B. Nare, D. Freedman, L. Hardy, and S.M. Beverley (1994), "PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate-resistance in the protozoan Leishmania major", Proc. Natl. Acad. Sci. USA 91: 11442-11446. 74. Turco, S.J., A. Descoteaux, K. Ryan, L.A. Garraway, and S.M. Beverley (1994), "Isolation of virulence genes directing GPI synthesis by functional complementation of Leishmania", Brazilian J. Med. Biol. Res. 27: 133-138. 73. Pimenta, P.F.P., E.M.B. Saraiva, E. Rowton, G.B. Modi, L.A. Garraway, S.M. Beverley, S.J. Turco, and D.L. Sacks (1994), "Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycan". Proc. Natl. Acad. Sci. USA 91: 9155-9159. 72. Gueiros-Filho, F.J., and S.M. Beverley (1994), "On the introduction of genetically modified Leishmania outside the laboratory", Exp. Parasitol.78: 425-428. 71. Fernandes, A.P., K. Nelson, and S.M. Beverley (1993), "Evolution of nuclear ribosomal RNAs in kinetoplastid protozoa: perspectives on the age and origins of parasitism", Proc. Natl. Acad. Sci. USA 90: 11608-11612. 70. Freedman, D.F., and S.M. Beverley (1993), "Two additional independent markers for transfection of Leishmania”. Mol. Biochem. Parasitology 62: 37-44. 69. Descoteaux, A., L.A. Garraway, K.A. Ryan, L.K. Garrity, S.J. Turco, and S.M. Beverley (1994), "Functional complementation of virulence genes in the protozoan parasite Leishmania", Methods in Molecular Genetics, K.W. Adolph ed., Vol 3, pp. 22-48. 68. Ryan, K.A., L.A. Garraway, A. Descoteaux, S.J. Turco, and S.M. Beverley (1993), "Isolation of virulence genes directing surface glycosyl-phosphatidylinositol synthesis by functional complementation of Leishmania". Proc. Natl. Acad. Sci. USA 90: 8609-8613. 67. Medina-Acosta, E., S.M. Beverley, and D.G. Russell (1993). "Evolution and expression of the Leishmania surface protease (gp63) gene locus". Infectious Agents and Disease 2: 25- 34. 66. Kaye, P.M., C.M. Coburn, M. McCrossan, and S.M. Beverley (1993). "Antigens targeted to the Leishmania phagolysosome are processed for CD4+ T-cell recognition". Eur. J. Immunol. 23: 2311-2319. 65. Ryan, K.A., S. Dasgupta, and S.M. Beverley, (1993), "Shuttle cosmid vectors for the trypanosomatid parasite Leishmania”, Gene 131: 145-50.

21

64. Garber, D.A., S.M. Beverley, and D.M. Coen (1993), "Demonstration of circularization of Herpes Simplex virus DNA following infection using pulsed field electrophoresis". Virology 197: 459-462. 63. LeBowitz, J.H., H.Q. Smith., L. Rusché, and S.M. Beverley (1993). "Coupling of poly(A) site selection and trans-splicing in Leishmania", Genes & Development 7: 996-1007. 62. Callahan, H.L., and S.M. Beverley (1992). "A member of the aldoketo-reductase family confers methotrexate resistance in Leishmania". J. Biol. Chem. 267: 24165-24168. 61. Uliana, S.R.B., K. Nelson, S.M. Beverley, E.P. Camargo, and L.M. Floeter-Winter (1994), "Discrimination amongst Leishmania by PCR amplification and hybridization with SSU rRNA-derived oligonucleotides." J. Eukaryotic Microbiology 41: 324-330. 60. López, J.A., J.H. LeBowitz, S.M. Beverley, H-G. Rammensee, and P. Overath (1992). "Leishmania mexicana promastigotes induce cytotoxic T lymphocytes in vivo that do not recognize infected macrophages". Eur. J. Immunol. 23: 217-223. 59. Cruz, A.K., R. Titus, and S.M. Beverley (1993). "Plasticity in chromosome number enables testing of essential genes in Leishmania by targeting." Proc. Natl. Acad. Sci. USA 90: 1599-1602. 58. Wilson, K., S.M. Beverley, and B. Ullman (1992), “Stable amplification of a linear extrachromosomal DNA in mycophenolic acid-resistant Leishmania donovani”. Mol. Biochem. Parasitol. 55: 197-206. 57. Hanson, S., S.M. Beverley, W. Wagner, and B. Ullman (1992), “Unstable Amplification of two extrachromosomal elements in a-difluoromethylornithine-resistant Leishmania donovani.” Mol. Cell. Biol 12: 5499-5507. 56. Briones, M.R.S., K. Nelson, S.M. Beverley, H.T. Affonso, E.P. Camargo, and L.M. Floeter- Winter (1992), "Leishmania tarentolae taxonomic relatedness inferred from phylogenetic analysis of small subunit ribosomal RNA genes", Mol. Biochem. Parasitol. 53: 121-128. 55. LeBowitz, J.H., A. Cruz, and S.M. Beverley (1992), "Thymidine kinase as a negative selectable marker in Leishmania major”, Molec. Biochem. Parasitol. 51: 321-326. 54. Cruz, A.C., C.M. Coburn, and S.M. Beverley. (1991), “Double targeted gene replacement in Leishmania major”. Memorias do Instituto Oswaldo Cruz, Vol. 86 Suppl I, 9-10. 53. Beverley, S.M, and C.E. Clayton (1993), “Transfection of Leishmania and Trypanosoma brucei by electroporation”. In: Hyde JE, ed. Protocols in Molecular Parasitology, Methods in Molecular Biology Vol 21, New Jersey: Humana Press, p. 333-348. 52. Callahan, H.L., and S.M. Beverley (1991), "Heavy metal resistance: a new role for P- glycoproteins in Leishmania", J. Biol. Chem. 266: 18427-18430. 51. Cruz, A., C.M. Coburn, and S.M. Beverley (1991), "Double targeted gene replacement for creating null mutants", Proc. Natl. Acad. Sci. USA 88: 7170-7174. 50. McMahon-Pratt, D., Y. Traub-Cseko, K. Lohman, D.D. Rogers, and S.M. Beverley (1992), "Loss of the GP46/M-2 surface membrane glycoprotein gene family in the Leishmania braziliensis complex", Mol. Biochem. Parasitol. 50: 151-160.

22

49. LeBowitz, J.H., C.M. Coburn, and S.M. Beverley (1991), "Simultaneous transient expression assays adapted for the trypanosomatid parasite Leishmania using ß-galactosidase and ß- glucuronidase as reporter enzymes", Gene 103: 119-123. 48. Beverley, S.M., "Gene amplification in Leishmania" (1991), Annu. Rev. Microb. 45: 417-44. 47. Coburn, C.M., K. Otteman, T.B. McNeely, S.J. Turco, and S.M. Beverley (1991), "Stable DNA Transfection of a wide range of trypanosomatids", Mol. Biochem. Parasitol. 46: 169- 179. 46. Panton, L.J., R.B. Tesh, K.C. Nadeau, and S.M. Beverley (1991), "A test for genetic exchange in mixed infections of Leishmania major in the sand fly Phlebotomus papatasi", J. Protozoology 38: 224-228. 45. Cruz, A., and S.M. Beverley (1990), "Gene replacement in parasitic protozoa", Nature 348: 171-4. 44. LeBowitz, J.H., C.M. Coburn, D. McMahon-Pratt, and S.M. Beverley (1990), "Development of a stable Leishmania expression vector and application to the study of parasite surface antigen genes", Proc. Natl. Acad. Sci. USA 87: 9736-40. 43. Beverley, S.M., C.M. Coburn, and G.M. Kapler (1991), "High-efficiency stable DNA transformation of the human parasite Leishmania major, The Biology of Parasitism, C.C. Wang, Ed., American Society for the Advancement of Science, p. 139-146. 42. Nelson,K., G. Alonso, P.J. Langer, and S.M. Beverley (1990), “Sequence of the dihydrofolate reductase-thymidylate synthase gene of Leishmania amazonensis”. Nucleic Acids Research 19: 2819 (for the record). 41. Kapler, G.M., K. Zhang, and S.M. Beverley (1990), "Nuclease mapping and DNA sequence analysis of transcripts from the dihydrofolate reductase-thymidylate synthase (R) region of Leishmania major", Nucleic Acids Research 18: 6399-6408. 40. Swafford, J.R., S.M. Beverley, C.C. Kan, and J.P. Caulfield (1990), "Distribution of dihydrofolate reductase-thymidylate synthase polypeptide in methotrexate resistant and wild-type Leishmania major: Evidence for cytoplasmic distribution despite a hydrophilic leader sequence", Proceedings of the XIIth International Congress of Electron Microscopy, p. 610-611. 39. Beverley, S.M., and C.M. Coburn (1990), "Recurrent de novo appearance of small linear DNAs in Leishmania major and relationship to extra-chromosomal DNAs observed in other species", Mol. Biochem. Parasitol. 42: 133-141. 38. Beverley, S.M. (1990), "Enzymatic amplification of RNA by Polymerase Chain Reaction", in Ausubel, F., Brent, R., Kingston, R., Moore, D., Seidman, J., Smith, J.A., and Struhl, K., Current Protocols in Molecular Biology, Greene Publishing Associates, New York, pages 15.4.1-15.4.6. 37. Kapler, G.M., C.M. Coburn, and S.M. Beverley (1990), "Stable Transfection of the human parasite Leishmania delineates a 30 kb region sufficient for extra-chromosomal replication and expression", Mol. Cell. Biol.10: 1084-1094. 36. Lopes, A.H. de C.S., D. Iovannisci, M. Petrillo-Peixoto, D. McMahon-Pratt, and S.M. Beverley (1990), "Evolution of nuclear DNA and the occurrence of sequences related to 23

new small chromosomal DNAs in the trypanosomatid genus Endotrypanum, Mol. Biochem. Parasitol. 40: 151-162. 35. Ellenberger, T.E., J.E. Wright, A. Rosowsky, and S.M. Beverley (1989), "Wild-type and drug-resistant Leishmania major hydrolyze methotrexate to N-10-methyl-4-deoxy-4- aminopteroate without accumulation of methotrexate polyglutamates", J. Biol. Chem. 264: 15960-15966. 34. Kapler, G.M., and S.M. Beverley (1989), "Transcriptional mapping of the amplified region encoding the dihydrofolate reductase-thymidylate synthase of Leishmania major reveals a high density of transcripts, including overlapping and antisense RNAs", Mol. Cell. Biol. 9: 3959-3972. 33. Ellenberger, T.E., and S.M. Beverley (1989), "Multiple drug resistance linked to conservative amplification of the H region in Leishmania major", J. Biol. Chem. 264: 15094-15103. 32. Iovannisci, D.M., and S.M. Beverley (1989), "Structural alterations of chromosome 2 in Leishmania major as evidence for diploidy, including spontaneous amplification of the mini-exon array". Mol. Biochem. Parasitol. 34:177-188. 31. Petrillo-Peixoto, M.L., and S.M. Beverley (1989), "Amplification of a new region of DNA in an unselected laboratory stock of Leishmania tarentolae: the T region", J. Protozoology 36: 257-261. 30. Beverley, S.M. (1989), "Estimation of circular DNA size using gamma-irradiation and pulsed field electrophoresis", Anal. Biochem. 177: 110-114. 29. Beverley, S.M., and M.L. Petrillo-Peixoto (1988), “Naturally-occurring gene amplifications conferring drug resistance in Leishmania tarentolae”. Memorias do Instituto Owaldo Cruz, Vol. 83, Suppl. I, p. 330-333. 28. Petrillo-Peixoto, M.L., and S.M. Beverley (1988), “Amplified DNAs in laboratory stocks of Leishmania tarentolae: extrachromosomal circles structurally and functionally similar to the inverted H region amplification of methotrexate-resistant L. major”. Mol. Cell. Biol. 8: 5188-5199. 27. Beverley, S.M., T.E. Ellenberger, and M.L. Petrillo-Peixoto (1989), "Unstable and stable gene amplification in methotrexate-resistant Leishmania major and natural isolates of Leishmania tarentolae, Leishmaniasis: The Current Status and New Strategies for Control, D.T. Hart, Ed., Plenum Press, New York p. 873-878. 26. Beach, D.H., L.J. Goad, J.D. Berman, T.E. Ellenberger, S.M. Beverley, and G.G. Holz Jr. (1989), "Effects of a squalene-2, 3-epoxidase inhibitor on propagation and sterol biosynthesis of Leishmania promastigotes and amastigotes", in Leishmaniasis: The current status and New Strategies for Control, D.T. Hart, Ed., Plenum Press, New York, p. 885- 890. 25. Beverley, S.M. (1988), "Characterization of the "unusual" mobility of large circular DNAs in pulsed field-gradient electrophoresis", Nucleic Acids Res. 16: 925-938. 24. Beverley, S.M., T.E. Ellenberger, D.M. Iovannisci, G.M. Kapler, M. Petrillo-Peixoto, and B.J. Sina. (1988), "Gene amplification in Leishmania", P.T. Englund, P.T., and A. Sher.

24

Biology of Parasitism, MBL Lectures in Biology, Vol 9. Alan Liss, Publishers, New York, pp 431-448. 23. Peixoto, M.P., and S.M. Beverley (1987), "In vitro activity of sulfonamides and sulfones on promastigotes of Leishmania major", Antimicrobial Agents & Chemotherapy 31: 1575-8. 22. Ellenberger, T.E., and S.M. Beverley (1987), "Biochemistry and regulation of folate and methotrexate transport in Leishmania major, J. Biol. Chem. 262: 10053-58. 21. Ellenberger, T.E., and S.M. Beverley (1987), "Reductions in methotrexate and folate uptake in methotrexate-resistant lines of Leishmania major are independent of gene amplification" J. Biol. Chem. 262: 13501-13506. 20. Beverley, S.M., R.B. Ismach, and D. McMahon-Pratt (1987), "Evolution of the genus Leishmania as revealed by comparisons of nuclear DNA restriction fragments", Proc. Natl. Acad. Sci. USA 84: 484-488. 19. Kapler, G.M., K. Zhang, and S.M. Beverley (1987), "Sequence and S1 nuclease mapping of the 5' region of the dihydrofolate reductase-thymidylate synthase gene of Leishmania major, Nucleic Acids Research 15: 3369-3383. 18. Beverley, S.M., R.B. Ismach, and D. McMahon-Pratt (1986), "Evolution of the genus Leishmania Ross (1903) as revealed by comparisons of nuclear DNA restriction fragment patterns", in Rioux, J.-A., Leishmania: Taxonomy and Phylogeny Applications to Ecology and Epidemiology Proceedings of International colloquium at Montpellier July 2-6 1984 Institut Mediterranean D'Etudes Epidemiologique et Ecologiques Press, Montepellier, p. 265-267. 17. Beverley, S.M., T.E. Ellenberger, and J.S. Cordingley (1986), "Primary structure of the gene encoding the bifunctional dihydrofolate reductase-thymidylate synthase of Leishmania major", Proc. Natl. Acad. Sci USA 83: 2585- 2588. 16. Beverley, S.M. and A.C. Wilson (1985), "Ancient Origin for Hawaiian Drosophilinae Inferred from Protein Comparisons", Proc. Natl. Acad. Sci. USA 82: 4800-4804. 15. Beverley, S.M., J.A. Coderre, D.V. Santi and R.T. Schimke (1984), "Unstable DNA Amplifications in methotrexate- resistant Leishmania consist of extra-chromosomal circles which relocalize during stabilization", Cell 38: 431-9. 14. Federspiel, N.A., S.M. Beverley, J. Schilling, and R.T. Schimke (1984), "Novel DNA rearrangements are associated with dihydrofolate reductase gene amplification", J. Biol. Chem. 259: 9127-9140. 13. Beverley, S.M. and A.C. Wilson (1984), "Molecular Evolution in Drosophila and the Higher Diptera, II: A Time Scale for Dipteran Evolution", J. Mol. Evol. 21: 1-13. 12. Garrett, C.E., J.A. Coderre, T.D. Meek, E.P. Garvey, D.M. Claman, S.M. Beverley and D.V. Santi (1983), "A bifunctional thymidylate synthase-dihydrofolate reductase in protozoa", Mol. Biochem. Parasitology 11: 257-265. 11. Coderre, J.A., S.M. Beverley, R.T. Schimke and D.V. Santi (1983), "Overproduction of a Bifunctional Thymidylate Synthase-Dihydrofolate Reductase and DNA Amplification in Methotrexate-Resistant Leishmania tropica", Proc. Natl. Acad. Sci. USA 80: 2132-2136.

25

10. Johnston, R.N., S.M. Beverley and R.T. Schimke (1983), "Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence-activated cell sorting", Proc. Natl. Acad. Sci. U.S.A. 80: 3711-3715. 9. Schimke, R.T., S.M. Beverley, P.C. Brown, R. Cassin, N. Federspiel, C. Gasser, A. Hill, R. Johnston, B. Mariani, E. Mosse, H. Rath, D. Smouse and T. Tlsty (1983), "Drug Resistance and Gene Amplification in Eukaryotic Cells", in Singer, T.P. and R.N. Ondarza, Mechanism of Drug Action, Academic Press, New York, p 107-117. 8. Santi, D.V., J.A. Coderre, S.M. Beverley and R.T. Schimke (1983), "Methotrexate-Resistant Leishmania tropica: A Model for Drug Resistance in Pathogenic Protozoa", Third John Jacob Abel Symposium on Drug Development: Molecular Parasitology, Academic Press, p. 107-121. 7. Schimke, R.T., S.M. Beverley, P.C. Brown, R. Cassin, N. Federspiel, C. Gasser, A. Hill, R. Johnston, B. Mariani, E. Mosse, H. Rath, D. Smouse and T. Tlsty (1983), "Gene Amplification and Drug Resistance in Cultured Animal Cells", in Cancer Treatment Reviews (International Symposium at Regensburg, FRG). 6. Beverley, S.M. and A.C. Wilson (1982), "Molecular Evolution in Drosophila and the Higher Diptera: I. Micro-complement Fixation Studies of a Larval Hemolymph Protein", J. Mol. Evol. 18: 251-264. 5. Schilling, J., S.M. Beverley, C. Simonsen, G. Crouse, D. Setzer, J. Feagin, M. McGrogan, N. Kohlmiller, R.T. Schimke (1982), "Dihydrofolate reductase gene structure and variable structure of amplified DNA in mouse cell lines", in R.T. Schimke, ed., Gene Amplification, Cold Spring Harbor Laboratory, p. 149 - 154. 4. Brown, P.C., S.M. Beverley and R.T. Schimke (1981), "Relationship of Amplified Dihydrofolate Reductase Genes to Double Minute Chromosomes in Unstably Resistant Mouse Fibroblast Cell Lines", Mol. Cell. Biology 1: 1077- 1083. 3. Haber, D.A., S.M. Beverley, M. Kiely and R.T. Schimke (1981) "Properties of an Altered Dihydrofolate Reductase Encoded by Amplified Genes in Cultured Mouse Fibroblasts", J. Biol. Chem. 256: 9501-9510. 2. Zimmer, E.A., S.L. Martin, S.M. Beverley, Y.W. Kan and A.C. Wilson (1980), "Rapid Duplication and Loss of Genes Coding for the Alpha Chain of Hemoglobin", Proc. Natl. Acad. Sci. USA 77: 2158-2162. 1. Beverley, S.M. (1979), "Molecular Evolution in Drosophila and the Higher Diptera", Ph.D. Thesis, University of California, Berkeley, 424 pp.

8. Patents.

US 05955333, “Double targeted gene replacement in unicellular diploid organisms”, S.M. Beverley and A.K. Cruz (issued 9/21/99). US 06020144, “Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same”, F. Gueiros-Filho, S.M. Beverley, D. Vaccaro (issued 2/1/00). US 06228649, “Double targeted gene replacement in unicellular diploid organisms”, S.M. Beverley and A.K. Cruz, (issued 5/8/01). 26

US 06410250, “Sustained delivery device and methods of making and using the same”, F. Gueiros-Filho, S.M. Beverley, and D. Vaccaro, (issued 6/25/02). US 07396811 “Subcellular targeting of therapeutic proteins”, J. H. LeBowitz and S.M. Beverley, (issued 7/08/08). US 07560424 “Targeted therapeutic proteins”, J. H. LeBowitz and S.M. Beverley, (issued 7/14/2009). US 07629309 “Targeted therapeutic proteins”, J.H. LeBowitz, S.M. Beverley and W. S. Sly, (issued 12/09/09). US 07858576 “Methods for targeting Lysosomal proteins”, J.H. LeBowitz and S.M. Beverley (issued 12/28/2010). US 08204114 “Targeted Therapeutic proteins”, J.H. LeBowitz, S.M. Beverley, and W.S. Sly, (issued 6/26/12). US 08492337 “Targeted Therapeutic proteins”, J.H. LeBowitz and S.M. Beverley, (issued 7/23/13). US 08492338 “Targeted Therapeutic proteins”, J.H. LeBowitz, S.M. Beverley, and W.S. Sly, (issued 7/23/13). US 08859498 “Targeted Therapeutic proteins”, J.H. LeBowitz and S.M. Beverley, (issued 10/14/14). US 09814762 “Targeted Therapeutic proteins”, J.H. LeBowitz and S.M. Beverley, (issued 11/14/17). US 10300113 “Targeted Therapeutic proteins”, J.H. LeBowitz and S.M. Beverley, (issued 5/28/19).

9. Invited Speaker

2020 Woods Hole Immunoparasitology meeting (Keynote speaker) University of Houston Duke University Medical School Distinguished Lecture, American Society of Microbiology, Missouri Branch (Kansas City) Neo-virology Meeting () ASBMB Wang Symposium in Molecular Parasitology

2019 St. Louis University Medical School (Division of Infectious Diseases, Allergy & Immunology) Graduate Student Distinguished Lecturer, Louisiana State Health Sciences Center (Shreveport) Gordon Research Conference on Tropical Infectious Diseases (Galveston) Keith Gull Celebration – a life in eukaryotic microbiology (Oxford) Stanford University School of Medicine (Dept. of Microbiology & Immunology) 18th Awaji International Forum on Infection and Immunity (, Japan). Molecular Parasitology Meeting (Woods Hole MA) – Keynote Speaker Distinguished Lecture, American Society of Microbiology, NW Branch (Seattle) CGID (Seattle) University of Illinois Champagne-Urbana (Pathobiology, College of Veterinary Medicine) 27

2018 American Society of Virology (College Park MD) Gordon Research Conference on Parasitism (Rhode Island) FASEB Microbial Glycobiology Meeting (Arizona) Conference on Neglected Tropical Diseases (Puerto Rico) University of Iowa Medical School (Iowa City) – Michael Apicella Lecture University of Arkansas Medical School Distinguished Lecturer (Little Rock)

2017 Global Health Symposium (Washington University St. Louis) University of California (Los Angeles). Gordon Research Conference on Tropical Infectious Diseases (Galveston) World Leish 6 (Toledo, Spain) Single Cell Genomics for Parasitologists (pre-meeting Course Director; American Society of Tropical Medicine, Baltimore)

2016 University of Notre Dame (student invite 2016) Johns Hopkins School of Public Health (student invite 2016) Gordon Conference on Biology of Parasitism (session chair; 2016) International Union of Biochemistry & Molecular Biology (Vancouver) (2016) Society of Brasilian Protozoology (Caxambu, 2016) American Society of Tropical Medicine & Hygiene (Atlanta 2016)

2015 Society of Brasilian Protozoology (Caxambu Brasil 2015) University of Pennsylvania (Microbiology) (2015) University of Pittsburgh (student invite 2015) Kinetoplastid Molecular Cell Biology Meeting (2015) Border Biomedical Research Center Symposium (U. Texas El Paso, 2015) Department of Virology and Immunology, Texas Biomedical Research Institute (San Antonio TX, 2015)

2014 Harvard Medical School (Microbiology) (2014) U.Texas Southwestern (2014) U. Virginia Charlottesville (Keynote Speaker – Infectious Disease & Biodefense Research Day) (2014) British Society of Parasitology (Cambridge UK) (2014) Trypanosomatid Research Workshop (Rio de Janeiro) (2014) Molecular Parasitology Meeting (Woods Hole MA) (2014) American Soc. Trop. Med. & Hygiene (New Orleans) (2014)

2013 U. Georgia (2013)

28

U. Tennessee Knoxville (2013) U. Wyoming Laramie (2013) World Leish 5 (Recife, Brasil) (2013) Evolutionary Genomics of Parasites (Sanger Center UK) (2013) Kinetoplastid Molecular & Cell Biology Meeting (Woods Hole MA) (2013) Washington University School of Medicine (Immunology Program) (2013)

2012 Harvard School of Public Health () (2012) ASBMB (San Diego) (2012) U. Lausanne (Switzerland) (2012) Cold Spring Harbor Asia Genomics & Infectious Disease () (2012) Microbial Lipids (Bern) (2012) U. California (Irvine) (2012) (New York) (2012)

2011 Seattle Biomedical Research Institute (2011) Glycobiology Society Annual Meeting (Seattle, 2011) Leishmania Genomes (Lausanne 2011) WHO course on Leishmania (Lausanne 2011) 1st Symposium on Infectious Diseases and Health Disparities in a Changing World (U. Texas El Paso, 2011) U. Calgary (2011) FASEB Microbial Polysaccharide Conference (2011) Keystone Symposium, “New Frontiers at the Interface of Immunity and Glycobiology” (2011) Kinetoplastid Molecular & Cell Biology Conference (2011) 2010 Oregon Health Sciences University (2010) University of (2010) Gordon Conference on Parasitism (2010) Harvard School of Public Health (2010) (2010) Collaborative Research Centre Symposium, "Control of Tropical Infectious Diseases”, (Heidelberg 2010) American Society of Microbiology Symposium “Microbial Glycobiology” (2010) American Society of Microbiology Symposium “Eating Information: Innate Immune Functions of the Phagolysosome” (2010)

2009 and before (Individual Dept Seminars Not included) American Society of Tropical Medicine and Hygiene (Washington DC, 2009) Molecular Parasitology Meeting (Session Chair) (2009) NIAID Conference on Collaborative Research Opportunities on Leishmania in North Africa & the Middle East (Tunisia, 2009) Society of Protozoloogy of Brasil (2009, Rio de Janeiro) International Symposium on Leishmaniasis Vaccines (Recife, 2009) Gordon Conference on Glycobiology (Ventura, 2009) 29

Society of Protozoology of Brazil (2008) Gordon Conference on Parasitism (2008) American Society of Tropical Medicine and Hygiene (Philadelphia, 2007) WG5-COST meeting on Drug resistance and Leishmaniasis (Quebec, 2007) Dormy House Meeting on Leishmaniasis (England, 2007) Gordon Conference on Sphingolipids (Ventura, 2006) NIH Eukaryotic Pathogens and Disease Vectors Sequencing Workshop (Bethesda, 2006) ASTMH Course on Parasite Knock-Ins and Knockouts (Atlanta, 2006) Glycobiology Society Meetings (Boston, 2005) ASM Annual Meeting (Atlanta, 2005) Chicago Area Mycology & Parasitology group (2005) Keystone Symposium on Drugs and Protozoans (Colorado, 2005) Gordon Conference on Parasitism (Rhode Island, 2004) “WU Day” on Microbial Pathogenesis; Institut Pasteur (Paris, 2003) American Society of Tropical Medicine and Hygiene (Philadelphia, 2003) 6th Annual Conference on New and Re-Emerging Infectious Diseases (Illinois, 2003) Tri-trypanosomatid Genome Meeting (Cambridge, 2003) International meeting on the cell and molecular biology of parasitic protozoa (Symposium in honor of Peter Overath (Schloss Ringberg, Germany, 2003) Seattle Protozoology Meeting (2003) American Society of Tropical Medicine and Hygiene (Denver, 2002) U. Pennsylvania Parasitology Retreat (2002) Pathogen Genomics (Sanger Centre, England 2002) Gordon Conference on Biology of Host-Parasite Interactions (Newport RI, 2002) Keystone Symposium on Drugs Against Tropical Protozoan Parasites (Keystone, CO 2002) Honors Program Lecturer, New York University (NY, NY 2001) Chagas’ Meeting (Caxambu, Brasil 2001) Tri-trypanosomatid Genome Meeting (Iguasu Falls, Brasil 2001) Glycobiology Meetings (San Francisco, 2001) Gordon Conference on Purines and Pyrimines (2001) Tri-trypanosomatid Genome Project (Cambridge UK, 2000) International Union of Biochemistry & Molecular Biology, FEBS (Birmingham UK, 2000) Evolution of pathogens and their hosts, Institute Pasteur (Speaker and co-organizer; Paris, 2000) Parasites and Pathogens, Annual meeting of Genetical Society of Great Britain (Warwick, 2000) New York Academy of Sciences (NY, 2000) Parasitism Gordon Research Conference (1999) ZMBH Forum on Cellular and molecular aspects of parasitic protozoa (Heidelberg, 1999) WHO Workshop on Transfection methods in malaria (, 1999) Brigitte Ogilvie Lecturer (University of Dundee, 1998) Inaugural Meeting of the School of Infection & Immunity, University of Glasgow (1998) Second Danforth Symposium (Washington University Medical School, 1998) Genetic Manipulation of Insects (Taos, 1998) International Meeting on Immuno-intervention (Tunisia, 1997) Molecular Parasitology/Vector Biology Symposium (University of Georgia, 1997) Swiss Trypanosomatid Meeting (1997) Special Programme on Molecular Parasitology, German Research Council (Cologne, 1996) Glycobiology society Meeting (Boston, 1996) WHO Meeting on Leishmania vaccination (Jordan, 1996) British Society of Parasitology Symposium (London, 1996) President's Symposium on Genetics of Intracellular Pathogens (ASBMB, New Orleans 1996) Jacques Monod Conference on Parasitism (Aussois, FR, 1996) 30

International Conference on Molecular Parasitology (Santiago Chile, 1996) Molecular and Immunological Aspects of Host-Parasite Interactions (Würzburg, 1996) Molecular Basis of Drug Resistance in Bacteria, Parasites and Fungi (Park City, 1996) Chagas' Disease Annual Meeting (Caxambú, Brasil 1995) Vaccines 100 Years after Pasteur (Paris, 1995) Workshop on Malaria Transfection (Leiden, 1995) Second Generation Vaccines Against leishmaniasis (Salvador, Brasil, 1995) Euroleish V Conference (Liverpool, 1994) American Society of Parasitology (Cincinnati, 1994) Jacques Monod Conference on Vaccine Development (Aussois FR, 1994) FASEB Conference on Microbial Pathogenesis (Vermont, 1994) Buffalo Conference on Microbial Pathogenesis (Buffalo, 1994) WHO TDR Directions Steering Committee (Geneva, 1993) American Society of Tropical Medicine and Hygiene (Atlanta, 1993) Mill Hill Lecturer (London, 1993) Recent Advances on enzymes in deoxyribonucleotide synthesis (Quebec, 1993) American Society of Cell Biology (Denver, 1992) Molecular biology of the trypanosomatid surface (Germany, 1992). MacArthur Workshop on transfection of malaria (Washington DC. 1992). DNA transfection of parasites (, 1992). UCLA meeting on Biological Basis of Parasitism (Park City, 1992) Gordon Research Conference on Parasitology: 1983, 1987, 1991, 1993, 1995; vice-chair, 1993; Chair, 1995. Guest lecturer, Woods Hole Course on the Biology of Parasitism (1985-92, 94-2001, 2003). American Society of Biological Chemistry (Philadelphia, 1987; Houston, 1992). Annual Meeting on Basic Research in Chagas' Disease, Caxambú Brasil, Nov, 1987, 1988, 1991, 1995. VIIth Meeting of the Brazilian Society of Protozooology, Caxambú Brasil, Nov. 1991. Banbury Conference on Electrophoresis of large DNA molecules: Theory, practice and future (1990). AAAS Symposium on Biology of Parasitism (New Orleans, 1990) "Frontiers of Molecular Parasitology" (University of Georgia, 1989). Welcome Molecular Parasitology Course, London, 1989,1990. ILRAD workshop on chemotherapy of trypanosomes (Nairobi, 1989). ILRAD workshop on "Genetic exchange in Trypanosomes" (Nairobi, 1986). American Society of Microbiology (Atlanta, 1987). American Society of Tropical Medicine and Hygiene (Denver, 1986), Chairman of Symposium on Occurrence and Mechanisms of Drug Resistance in Parasites Potential Impact of modern genetic, biochemical and immunological techniques on the study of human leishmaniasis (England, 1985). Leishmaniasis: the first centenary (1885-1985), New Strategies for Control, Zakinthos, Greece (1987). Bellagio conference on Pharmacological perspectives on the Molecular biology of parasites (1986).

10. Community Service.

Clayton Youth Sports League Coach (head or assistant): boys soccer - 2006-2015 Coach (head or assistant): boys baseball - 2007-2016

31